
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Medications for Acute Coronary Syndromes - Cardiovascular Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "fbc4b0ec-6fa3-474b-9ccf-5de368a19e06";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v27853685";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "03ade11a-c57a-4365-b901-d4ca06a5edf0",
 VasontId : "v934001"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "ee8ab93f-6fdb-4525-b9c2-55a87a4f1a0c",
 VasontId : "v878834"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'd6373e9d-ee7e-489c-90b3-1f961aac0cbd';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Medications for Acute Coronary Syndromes
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/sweis-ranya.html">Ranya N. Sweis</a></strong>
 <p class="topic__authors--description">, MD, MS, Northwestern University Feinberg School of Medicine;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/jivan-arif.html">Arif Jivan</a></strong>
 <p class="topic__authors--description">, MD, PhD, Northwestern University Feinberg School of Medicine</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Feb 2024 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="MM1108" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v27854127" class="topicmenu_mobile__paragraph">Antiplatelet Agents</a>
 </li>
 <li>
 <a href="#v27854146" class="topicmenu_mobile__paragraph">Anticoagulant Agents</a>
 </li>
 <li>
 <a href="#v27854173" class="topicmenu_mobile__paragraph">Beta-Blockers</a>
 </li>
 <li>
 <a href="#v27854186" class="topicmenu_mobile__paragraph">Nitrates</a>
 </li>
 <li>
 <a href="#v27854193" class="topicmenu_mobile__paragraph">Fibrinolytics</a>
 </li>
 <li>
 <a href="#v27859162" class="topicmenu_mobile__paragraph">Other Medications</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Calculators'); }, keypress: function() { $data.activateGroup('Calculators'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Calculators (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Intracranial Bleeding Risk from Thrombolytic Therapy of MI">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Intracranial Bleeding Risk...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/IntracranialBleedingRiskThrombolytics.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"2c830a78-26a1-47c7-af59-b6be1b4835f1","Title":"Intracranial%20Bleeding%20Risk%20from%20Thrombolytic%20Therapy%20of%20MI","ShareUrlTitle":"intracranial-bleeding-risk-from-thrombolytic-therapy-of-mi","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Intracranial%20Bleeding%20Risk%20from%20Thrombolytic%20Therapy%20of%20MI","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Images (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (3)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Medications for Coronary Artery Disease*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Medications for Coronary...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"fd7f2e57-cf0e-41ee-b261-6294110819a0","Title":"Medications%20for%20Coronary%20Artery%20Disease%2A","ShareUrlTitle":"medications-for-coronary-artery-disease","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v88176366","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Medications%20for%20Coronary%20Artery%20Disease%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="IV Fibrinolytic Therapies">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 IV Fibrinolytic Therapies
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"264a5913-aa83-4ff2-bf45-96524eba3735","Title":"IV%20Fibrinolytic%20Therapies","ShareUrlTitle":"iv-fibrinolytic-therapies","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v27854207","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"IV%20Fibrinolytic%20Therapies","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Contraindications to Fibrinolytic Therapy">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Contraindications to Fibrinolytic...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"66a3b179-040d-4ffb-9f1d-2fda4899857a","Title":"Contraindications%20to%20Fibrinolytic%20Therapy","ShareUrlTitle":"contraindications-to-fibrinolytic-therapy","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v41360653","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Contraindications%20to%20Fibrinolytic%20Therapy","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v27853729" class="anchor"></span><div class="para"> <p>Treatment of <a href="./{77C0CDF2-C352-414E-BD93-B44680DB73E6}.html" data-toggle="tooltip" title="Overview of Acute Coronary Syndromes (ACS)" data-id="9c38a652-a004-455a-b01a-bf0a03ec462b" data-itemid="77c0cdf2-c352-414e-bd93-b44680db73e6">acute coronary syndromes</a><span id="9c38a652-a004-455a-b01a-bf0a03ec462b" class="d-none xref"> <span class="tooltip-container"> <a href="./{77C0CDF2-C352-414E-BD93-B44680DB73E6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Acute Coronary Syndromes (ACS) </span> Acute coronary syndromes result from acute obstruction of a coronary artery. Consequences depend on degree and location of obstruction and range from unstable angina to non–ST-segment elevation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications. An ACS is a medical emergency; outcome is greatly influenced by rapid diagnosis and treatment. Treatment occurs simultaneously with diagnosis. Treatment includes <a href="./{528946F8-04D5-4DB7-B03B-1A97B7391290}.html" data-toggle="tooltip" title="Overview of Revascularization for Acute Coronary Syndromes" data-id="7aac168c-9e04-4e08-a6d5-53be443f504b" data-itemid="528946f8-04d5-4db7-b03b-1a97b7391290">revascularization</a><span id="7aac168c-9e04-4e08-a6d5-53be443f504b" class="d-none xref"> <span class="tooltip-container"> <a href="./{528946F8-04D5-4DB7-B03B-1A97B7391290}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Revascularization for Acute Coronary Syndromes </span> Revascularization is the restoration of blood supply to ischemic myocardium in an effort to limit ongoing damage, reduce ventricular irritability, and improve short-term and long-term outcomes... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (with <a href="./{42CA570B-3240-4095-B59E-C84C0C50A0B6}.html" data-toggle="tooltip" title="Percutaneous Coronary Interventions (PCI)" data-id="fd0ee47c-cff1-46b0-b3bc-fae9751f86d0" data-itemid="42ca570b-3240-4095-b59e-c84c0c50a0b6">percutaneous coronary intervention</a><span id="fd0ee47c-cff1-46b0-b3bc-fae9751f86d0" class="d-none xref"> <span class="tooltip-container"> <a href="./{42CA570B-3240-4095-B59E-C84C0C50A0B6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Percutaneous Coronary Interventions (PCI) </span> Percutaneous coronary interventions (PCI) include percutaneous transluminal coronary angioplasty (PTCA) with or without stent insertion. Primary indications are treatment of Angina pectoris... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0237541-percutaneous-coronary-intervention-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Percutaneous Coronary Interventions (PCI)" loading="lazy"> </span> </a> </span> </span>, <a href="./{2153B115-2E0E-45E2-B162-AF9479C5FA5D}.html" data-toggle="tooltip" title="Coronary Artery Bypass Grafting (CABG)" data-id="e3918249-2e46-460f-a00e-e4b0cac9acb0" data-itemid="2153b115-2e0e-45e2-b162-af9479c5fa5d">coronary artery bypass grafting</a><span id="e3918249-2e46-460f-a00e-e4b0cac9acb0" class="d-none xref"> <span class="tooltip-container"> <a href="./{2153B115-2E0E-45E2-B162-AF9479C5FA5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Coronary Artery Bypass Grafting (CABG) </span> Coronary artery bypass grafting (CABG) involves bypassing native coronary arteries that have high-grade stenosis or occlusion not amenable to angioplasty with stent insertion. Indications are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/a/b/cabg_sutures_and_clips_1_and_2_combined.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Coronary Artery Bypass Grafting (CABG)" loading="lazy"> </span> </a> </span> </span>, or fibrinolytic therapy) and pharmacologic therapy to treat ACS and underlying <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html" data-toggle="tooltip" title="Overview of Coronary Artery Disease" data-id="6f3ad370-0400-40df-9746-6c9595e6145a" data-itemid="b08a09f4-f747-4fa0-985e-90465f8128c5">coronary artery disease</a><span id="6f3ad370-0400-40df-9746-6c9595e6145a" class="d-none xref"> <span class="tooltip-container"> <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Coronary Artery Disease </span> Coronary artery disease (CAD) involves impairment of blood flow through the coronary arteries, most commonly by atheromas. Clinical presentations include silent ischemia, angina pectoris, acute... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/a/n/g/angioplasty_stent_01_high_blausen.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Coronary Artery Disease" loading="lazy"> </span> </a> </span> </span>. </p></div><span id="v27853735" class="anchor"></span><div class="para"> <p>Medications used depend on the type of ACS and include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v27853738" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clopidogrel</span>, or both (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prasugrel</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ticagrelor</span> are alternatives to <span class="genericDrug" data-showrollover="false">clopidogrel</span> if fibrinolytic therapy has not been given)</p></div></li><li class="topic__listitem"><span id="v27853740" class="anchor"></span><div class="para"> <p>Beta-blocker</p></div></li><li class="topic__listitem"><span id="v27853742" class="anchor"></span><div class="para"> <p>Glycoprotein IIb/IIIa inhibitor for certain patients undergoing percutaneous coronary intervention (PCI) and high-risk lesions (eg, high thrombus burden, no reflow)</p></div></li><li class="topic__listitem"><span id="v27853744" class="anchor"></span><div class="para"> <p>A <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> (unfractionated or low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span>) or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bivalirudin</span> (particularly in patients with <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="a9d1fdaa-007a-44d1-8ea6-f6d56b163907" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">ST-segment elevation myocardial infarction</a><span id="a9d1fdaa-007a-44d1-8ea6-f6d56b163907" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span> [STEMI] who are at high risk of bleeding)</p></div></li><li class="topic__listitem"><span id="v27853747" class="anchor"></span><div class="para"> <p>IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span> (unless low-risk, uncomplicated <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="d35004c4-3a8c-4c58-9630-397c00db86f6" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">myocardial infarction</a><span id="d35004c4-3a8c-4c58-9630-397c00db86f6" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v27853750" class="anchor"></span><div class="para"> <p>Fibrinolytics for select patients with STEMI when timely PCI unavailable</p></div></li><li class="topic__listitem"><span id="v27853752" class="anchor"></span><div class="para"> <p>Angiotensin-converting enzyme (ACE) inhibitor (as early as possible)</p></div></li><li class="topic__listitem"><span id="v27853754" class="anchor"></span><div class="para"> <p>Statins</p></div></li></ul></div><span id="v27853755" class="anchor"></span><div class="para"> <p>Antiplatelet and antithrombotic drugs, which stop clots from forming, are used routinely. Anti-ischemic drugs (eg, beta-blockers, IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span>) are frequently added, particularly when chest pain or hypertension is present (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"fd7f2e57-cf0e-41ee-b261-6294110819a0","Title":"Medications%20for%20Coronary%20Artery%20Disease%2A","ShareUrlTitle":"medications-for-coronary-artery-disease","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v88176366","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EMedications%20for%20Coronary%20Artery%20Disease%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). </p></div><span id="v27853757" class="anchor"></span><div class="para"> <p> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v27854194" data-toggle="tooltip" title="Fibrinolytics" data-id="bdf58bf7-922d-4e68-9826-99d07d18dbd1" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">Fibrinolytics</a><span id="bdf58bf7-922d-4e68-9826-99d07d18dbd1" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v27854194"> <span class="tooltip-content"> <span class="tooltip-heading"> Fibrinolytics </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span><i>should be used if not contraindicated</i> for STEMI if primary PCI is not immediately available but worsen outcome for <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html" data-toggle="tooltip" title="Unstable Angina" data-id="0e7b4682-407a-43de-8008-50268a0cfcbe" data-itemid="f5554f32-c171-4894-9a7d-5bc591853560">unstable angina</a><span id="0e7b4682-407a-43de-8008-50268a0cfcbe" class="d-none xref"> <span class="tooltip-container"> <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Unstable Angina </span> Unstable angina results from acute obstruction of a coronary artery without myocardial infarction. Symptoms include chest discomfort with or without dyspnea, nausea, and diaphoresis. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660" data-toggle="tooltip" title="Infarct extent" data-id="87ad9e45-e208-4104-b5bd-acd7faaf22a9" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">non-ST elevation myocardial infarction</a><span id="87ad9e45-e208-4104-b5bd-acd7faaf22a9" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660"> <span class="tooltip-content"> <span class="tooltip-heading"> Infarct extent </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infarct extent" loading="lazy"> </span> </a> </span> </span> (NSTEMI).</p></div><span id="v27853760" class="anchor"></span><div class="para"> <p>Chest pain can be treated with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span> or sometimes <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>morphine</span>. <span class="genericDrug" data-showrollover="false">Nitroglycerin</span> is preferable to <span class="genericDrug" data-showrollover="false">morphine</span>, which should be used judiciously (eg, if a patient has a contraindication to <span class="genericDrug" data-showrollover="false">nitroglycerin</span> or is in pain despite <span class="genericDrug" data-showrollover="false">nitroglycerin</span> therapy). <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v27854187" data-toggle="tooltip" title="Nitrates" data-id="84c625eb-d518-40c8-8195-9f8627737b64" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span></a><span id="84c625eb-d518-40c8-8195-9f8627737b64" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v27854187"> <span class="tooltip-content"> <span class="tooltip-heading"> Nitrates </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is initially given sublingually, followed by continuous IV drip if needed. <span class="genericDrug" data-showrollover="false">Morphine</span> 2 to 4 mg IV, repeated every 15 minutes as needed, is highly effective but can depress respiration, can reduce myocardial contractility, and is a potent venous vasodilator. Evidence also suggests that <span class="genericDrug" data-showrollover="false">morphine</span> interferes with some P2Y12 receptor inhibitors. A large retrospective trial showed that <span class="genericDrug" data-showrollover="false">morphine</span> may increase mortality in patients with acute myocardial infarction (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v41360611" data-toggle="tooltip" title="References" data-id="8c8c978b-2141-448e-abf4-16803b225006" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">1, 2</a><span id="8c8c978b-2141-448e-abf4-16803b225006" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v41360611"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Hypotension and bradycardia secondary to <span class="genericDrug" data-showrollover="false">morphine</span> can usually be overcome by prompt elevation of the lower extremities. </p></div><span id="v27853763" class="anchor"></span><div class="para"> <p>Blood pressure (BP) is normal or slightly elevated in most patients on arrival at the emergency department; BP gradually falls over the next several hours. Continued hypertension requires treatment with antihypertensives, preferably IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span>, to lower BP and reduce cardiac workload. Severe hypotension or other signs of <a href="./{325CC6A6-C2A7-4B95-A6DC-7BB5B819D97F}.html" data-toggle="tooltip" title="Shock" data-id="41d972bd-19aa-42f3-9cc0-3060f0605b1c" data-itemid="325cc6a6-c2a7-4b95-a6dc-7bb5b819d97f">shock</a><span id="41d972bd-19aa-42f3-9cc0-3060f0605b1c" class="d-none xref"> <span class="tooltip-container"> <a href="./{325CC6A6-C2A7-4B95-A6DC-7BB5B819D97F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Shock </span> Shock is a state of organ hypoperfusion with resultant cellular dysfunction and death. Mechanisms may involve decreased circulating volume, decreased cardiac output, and vasodilation, sometimes... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> are ominous and must be treated aggressively with IV fluids and sometimes vasopressors.</p></div> <span id="v88175914"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v88176367"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"fd7f2e57-cf0e-41ee-b261-6294110819a0","Title":"Medications%20for%20Coronary%20Artery%20Disease%2A","ShareUrlTitle":"medications-for-coronary-artery-disease","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v88176366","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Medications%20for%20Coronary%20Artery%20Disease%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="fd7f2e57-cf0e-41ee-b261-6294110819a0"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'fd7f2e57-cf0e-41ee-b261-6294110819a0' }, async: true, success: function (data) { $('#fd7f2e57-cf0e-41ee-b261-6294110819a0').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <section id="v41360610" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v41360611" class="anchor"></span> References </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v41360614" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/15976786">Meine TJ, Roe MT, Chen AY, et al</a>: Association of intravenous <span class="genericDrug" data-showrollover="false">morphine</span> use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. <i>Am Heart J</i> 149(6):1043-1049, 2005. doi 10.1016/j.ahj.2005.02.010 </p></div></li><li class="topic__listitem"><span id="v41360618" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712351/">Kubica J, Adamski P, Ostrowska M, et al</a>: <span class="genericDrug" data-showrollover="false">Morphine</span> delays and attenuates <span class="genericDrug" data-showrollover="false">ticagrelor</span> exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. <i>Eur Heart J</i> 37(3):245–252, 2016. doi: 10.1093/eurheartj/ehv547</p></div></li></ul></div> </div> </section> <section id="v27854127" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v27854128" class="anchor"></span> Antiplatelet Agents </h2> <div class="topic__content"> <span id="v27854134" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clopidogrel</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prasugrel</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ticagrelor</span>, ticlopidine, and glycoprotein (GP) IIb/IIIa inhibitors are examples of antiplatelet agents. All patients are given <span class="genericDrug" data-showrollover="false">aspirin</span> 160 to 325 mg (not enteric-coated), if not contraindicated (eg, life-threatening active bleeding), at presentation and 81 mg once a day indefinitely thereafter. Chewing the first dose before swallowing quickens absorption. <span class="genericDrug" data-showrollover="false">Aspirin</span> reduces short- and long-term mortality risk (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v41360626" data-toggle="tooltip" title="Antiplatelet agent reference" data-id="7c23d4a6-dbea-4eac-9e4a-630d8fb82e4f" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">1</a><span id="7c23d4a6-dbea-4eac-9e4a-630d8fb82e4f" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v41360626"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiplatelet agent reference </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v27854135" class="anchor"></span><div class="para"> <p>If <span class="genericDrug" data-showrollover="false">aspirin</span> cannot be taken, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clopidogrel</span> 75 mg orally once a day or ticlopidine 250 mg orally twice a day may be used. <span class="genericDrug" data-showrollover="false">Clopidogrel</span> has largely replaced <span class="genericDrug" data-showrollover="false">ticlopidine</span> for routine use because neutropenia is a risk with <span class="genericDrug" data-showrollover="false">ticlopidine</span>, and the white blood cell count must be monitored regularly if patients are taking <span class="genericDrug" data-showrollover="false">ticlopidine</span>. </p></div> <section id="v27854136" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27854137" class="anchor"></span> Patients not undergoing revascularization </h3> <div class="topic__content"> <span id="v27854138" class="anchor"></span><div class="para"> <p>Patients with <a href="./{77C0CDF2-C352-414E-BD93-B44680DB73E6}.html" data-toggle="tooltip" title="Overview of Acute Coronary Syndromes (ACS)" data-id="8efe77e5-6f41-42a6-8c2e-a57575701e3a" data-itemid="77c0cdf2-c352-414e-bd93-b44680db73e6">acute coronary syndrome</a><span id="8efe77e5-6f41-42a6-8c2e-a57575701e3a" class="d-none xref"> <span class="tooltip-container"> <a href="./{77C0CDF2-C352-414E-BD93-B44680DB73E6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Acute Coronary Syndromes (ACS) </span> Acute coronary syndromes result from acute obstruction of a coronary artery. Consequences depend on degree and location of obstruction and range from unstable angina to non–ST-segment elevation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (ACS) in whom intervention is not possible or recommended are given both <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>aspirin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clopidogrel</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ticagrelor</span>) for at least 12 months. In general, the concern with dosage and duration of antiplatelet agents is to balance the decreased risk of coronary thrombosis with the increased risk of bleeding.</p></div> </div> </section> <section id="v27854142" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27854143" class="anchor"></span> Patients undergoing revascularization </h3> <div class="topic__content"> <span id="v27854144" class="anchor"></span><div class="para"> <p>In patients undergoing <a href="./{528946F8-04D5-4DB7-B03B-1A97B7391290}.html" data-toggle="tooltip" title="Overview of Revascularization for Acute Coronary Syndromes" data-id="b334ab97-6d8f-42c4-a8bb-9eb176e64641" data-itemid="528946f8-04d5-4db7-b03b-1a97b7391290">PCI</a><span id="b334ab97-6d8f-42c4-a8bb-9eb176e64641" class="d-none xref"> <span class="tooltip-container"> <a href="./{528946F8-04D5-4DB7-B03B-1A97B7391290}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Revascularization for Acute Coronary Syndromes </span> Revascularization is the restoration of blood supply to ischemic myocardium in an effort to limit ongoing damage, reduce ventricular irritability, and improve short-term and long-term outcomes... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, a loading dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clopidogrel</span> (300 to 600 mg orally once), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prasugrel</span> (60 mg orally once), or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ticagrelor</span> (180 mg orally once) improves outcomes (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v41360626" data-toggle="tooltip" title="Antiplatelet agent reference" data-id="453a0bfd-fe1c-4571-ba04-6f33ea9df87c" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">1</a><span id="453a0bfd-fe1c-4571-ba04-6f33ea9df87c" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v41360626"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiplatelet agent reference </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v41360624" class="anchor"></span><div class="para"> <p>Some clinicians give a GP IIb/IIIa inhibitor during PCI to all high-risk patients (eg, those with markedly elevated cardiac biomarkers, a TIMI risk score <span class='symbol'>≥</span> 4, or persistent symptoms despite adequate pharmacologic therapy) with large thrombus burden. The GP IIb/IIIa inhibitor is continued for 6 to 24 hours, and angiography is done before the infusion period is over. GP IIb/IIIa inhibitors are not recommended for patients receiving fibrinolytics. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abciximab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tirofiban</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>eptifibatide</span> appear to have equivalent efficacy, and the choice of agent should depend on other factors (eg, cost, availability, familiarity).</p></div><span id="v27854145" class="anchor"></span><div class="para"> <p>For patients receiving a stent for revascularization, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>aspirin</span> is continued indefinitely. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clopidogrel</span> 75 mg orally once a day, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prasugrel</span> 10 mg orally once a day, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ticagrelor</span> 90 mg orally twice a day should be used for at least 1 month in patients with a bare-metal stent. Patients with a drug-eluting stent after ACS have a prolonged risk of thrombosis and benefit from up to 12 months of <span class="genericDrug" data-showrollover="false">clopidogrel</span> (or <span class="genericDrug" data-showrollover="false">prasugrel</span> or <span class="genericDrug" data-showrollover="false">ticagrelor</span>) treatment.</p></div> </div> </section> <section id="v41360625" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v41360626" class="anchor"></span> Antiplatelet agent reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v67158565" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34895950/">Lawton JS, Tamis-Holland JE, Bangalore S, et al</a>: 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the ACC/AHA Joint Committee on Clinical Practice Guidelines. <i>J Am Coll Cardiol</i> 79(2):e21–e129, 2022. doi: 10.1016/j.jacc.2021.09.006</p></div></li></ul></div> </div> </section> </div> </section> <section id="v27854146" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v27854147" class="anchor"></span> Anticoagulant Agents </h2> <div class="topic__content"> <span id="v27854151" class="anchor"></span><div class="para"> <p>Either a low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span> (LMWH), unfractionated <span class="genericDrug" data-showrollover="false">heparin</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bivalirudin</span> is given routinely to patients with acute coronary syndrome unless contraindicated (eg, by active bleeding or planned use of streptokinase or anistreplase). Choice of agent depends on whether revascularization is anticipated, as well as other factors such as patient characteristics, cost, and local practice.</p></div><span id="v27854152" class="anchor"></span><div class="para"> <p>Patients at high risk of systemic emboli (eg, <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html#v21366431" data-toggle="tooltip" title="CHA2DS2-VASc Score" data-id="161127f5-6b7d-4bf9-8d72-10b23a6d45f1" data-itemid="3118c057-fb1f-4aa1-8b87-c346cbc408c3">atrial fibrillation with CHA2DS2VASc score</a><span id="161127f5-6b7d-4bf9-8d72-10b23a6d45f1" class="d-none xref"> <span class="tooltip-container"> <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html#v21366431"> <span class="tooltip-content"> <span class="tooltip-heading"> CHA2DS2-VASc Score </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="CHA2DS2-VASc Score" loading="lazy"> </span> </a> </span> </span> ≥ 2) also require long-term therapy with an oral anticoagulant (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>). Conversion to oral anticoagulants should begin 48 hours after symptom resolution or PCI.</p></div> <section id="v27854153" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27854154" class="anchor"></span> Unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> </h3> <div class="topic__content"> <span id="v27854155" class="anchor"></span><div class="para"> <p>Unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is more complicated to use because it requires frequent (every 6 hours) dosing adjustments to achieve an activated partial thromboplastin time (aPTT) 1.5 to 2 times the control value. In patients undergoing angiography, further dosing adjustment is done to achieve an activated clotting time (ACT) of 200 to 250 seconds if the patient is treated with a GP IIb/IIIa inhibitor and 250 to 300 seconds if a GP IIb/IIIa inhibitor is not being given. However, if bleeding develops after catheterization, the effects of unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> are shorter and can be reversed (by promptly stopping the <span class="genericDrug" data-showrollover="false">heparin</span> infusion and giving <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> sulfate).</p></div> </div> </section> <section id="v27854156" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27854157" class="anchor"></span> Low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span> </h3> <div class="topic__content"> <span id="v27854158" class="anchor"></span><div class="para"> <p>The LMWHs have better bioavailability, are given by simple weight-based dosing without monitoring aPTT and dose titration, and have lower risk of <span class="genericDrug" data-showrollover="false">heparin</span>-induced thrombocytopenia. They also may produce an incremental benefit in outcomes relative to unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> in patients with ACS. Of the LMWHs, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span> appears to be superior to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dalteparin</span> or nadroparin. However, <span class="genericDrug" data-showrollover="false">enoxaparin</span> may pose a higher bleeding risk in patients with STEMI who are <span class='symbol'>></span> 75 years, and its effects are not completely reversible with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span>.</p></div> </div> </section> <section id="v27854159" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27854160" class="anchor"></span> Choice of <span class="genericDrug" data-showrollover="false">heparin</span> </h3> <div class="topic__content"> <span id="v27854161" class="anchor"></span><div class="para"> <p>Thus, taking all into account, many published guidelines recommend LMWH (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span>) over unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> in patients with unstable angina or NSTEMI and in patients <span class='symbol'>&lt</span> age 75 years with STEMI who are not undergoing PCI. </p></div><span id="v27854163" class="anchor"></span><div class="para"> <p>By contrast, unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is recommended when emergency PCI is done (eg, patients with acute STEMI who proceed to the catheterization laboratory), when CABG is indicated within the next 24 hours, and when patients are at high risk of bleeding complications (eg, history of gastrointestinal bleeding within the last 6 months) or have creatinine clearance <span class='symbol'>&lt</span> 30 mL/minute (0.5 mL/second). </p></div><span id="v27854164" class="anchor"></span><div class="para"> <p>For patients undergoing PCI, post-procedure <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is no longer recommended unless patients are at high risk of thromboembolic events (eg, patients with large anterior MI, known LV thrombus, atrial fibrillation), because postprocedure ischemic events have decreased with the use of stents and antiplatelet agents. For patients not undergoing PCI, <span class="genericDrug" data-showrollover="false">heparin</span> is continued for 48 hours (or longer if symptoms persist).</p></div> </div> </section> <section id="v27859034" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27859035" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Heparin</span> alternatives </h3> <div class="topic__content"> <span id="v41439932" class="anchor"></span><div class="para"> <p>The difficulties with the heparins (including bleeding complications, the possibility of <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="f686a4d1-e409-42a8-bef4-872b1a0f8c1f" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="f686a4d1-e409-42a8-bef4-872b1a0f8c1f" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and, with unfractionated <span class="genericDrug" data-showrollover="false">heparin</span>, the need for dosing adjustments) have led to the search for alternative anticoagulants. </p></div><span id="v41439934" class="anchor"></span><div class="para"> <p>The direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bivalirudin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>argatroban</span>, may have a lower incidence of serious bleeding and improved outcomes, particularly in patients with renal insufficiency (hirudin, another direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitor, appears to cause more bleeding than the other agents). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bivalirudin</span> is an acceptable alternative to unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> for patients undergoing PCI who are at high risk of bleeding. The <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span> reduces mortality and reinfarction in patients with NSTEMI who undergo PCI without increasing bleeding but has no clear benefit compared with unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> in patients with STEMI (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v88135955" data-toggle="tooltip" title="Anticoagulants reference" data-id="53e4fbee-04a7-4358-a72d-a531149b2e10" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">1</a><span id="53e4fbee-04a7-4358-a72d-a531149b2e10" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v88135955"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulants reference </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Although routine use of these alternative anticoagulants is thus not currently recommended, they should be used in place of unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> or LMWH in patients with a known or suspected history of <span class="genericDrug" data-showrollover="false">heparin</span>-induced thrombocytopenia.</p></div><span id="v88135952" class="anchor"></span><div class="para"> <p>For patients who require anticoagulation for another reason (eg, <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html" data-toggle="tooltip" title="Atrial Fibrillation" data-id="83be9c26-c2b0-46aa-80d8-edafce2b07c7" data-itemid="3118c057-fb1f-4aa1-8b87-c346cbc408c3">atrial fibrillation</a><span id="83be9c26-c2b0-46aa-80d8-edafce2b07c7" class="d-none xref"> <span class="tooltip-container"> <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atrial Fibrillation </span> Atrial fibrillation is a rapid, irregularly irregular atrial rhythm. Symptoms include palpitations and sometimes weakness, effort intolerance, dyspnea, and presyncope. Atrial thrombi may form... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), direct-acting oral anticoagulants (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>) are preferred long term over <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, unless there is a contraindication to them. For most patients requiring anticoagulation, triple therapy with oral anticoagulation, a P2Y12 inhibitor, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>aspirin</span> is continued up to 1 week to 1 month after intervention, and then patients are continued on oral anticoagulation and a P2Y12 inhibitor for 6 months to 1 year. Calcium channel blockers and nitrates may also be given to reduce risk of coronary spasm.</p></div> </div> </section> <section id="v88135954" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v88135955" class="anchor"></span> Anticoagulants reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v88135958" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/16537725/">Yusuf S, Mehta SR, Chrolavicius S, et al</a>. Effects of <span class="genericDrug" data-showrollover="false">fondaparinux</span> on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. <i>JAMA</i> 2006;295(13):1519-1530. doi:10.1001/jama.295.13.joc60038</p></div></li></ul></div> </div> </section> </div> </section> <section id="v27854173" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v27854174" class="anchor"></span> Beta-Blockers </h2> <div class="topic__content"> <span id="v27854176" class="anchor"></span><div class="para"> <p>Beta-blockers are recommended unless contraindicated (eg, by bradycardia, <a href="./{6DAA6064-7FA0-4A0C-B5A7-32DCC33D4B03}.html" data-toggle="tooltip" title="Atrioventricular Block" data-id="5e0dd433-3a38-4fdc-8c79-3e77b414831e" data-itemid="6daa6064-7fa0-4a0c-b5a7-32dcc33d4b03">heart block</a><span id="5e0dd433-3a38-4fdc-8c79-3e77b414831e" class="d-none xref"> <span class="tooltip-container"> <a href="./{6DAA6064-7FA0-4A0C-B5A7-32DCC33D4B03}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atrioventricular Block </span> Atrioventricular (AV) block is partial or complete interruption of impulse transmission from the atria to the ventricles. The most common cause is idiopathic fibrosis and sclerosis of the conduction... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/o/b/mobitz-i-four-to-three-cropped-annotated-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Atrioventricular Block" loading="lazy"> </span> </a> </span> </span>, hypotension, or <a href="./{7E52EFBA-8905-43F4-9408-53B7471DEB80}.html" data-toggle="tooltip" title="Asthma" data-id="b673cfbe-af49-4521-92b4-1954027fab93" data-itemid="7e52efba-8905-43f4-9408-53b7471deb80">asthma</a><span id="b673cfbe-af49-4521-92b4-1954027fab93" class="d-none xref"> <span class="tooltip-container"> <a href="./{7E52EFBA-8905-43F4-9408-53B7471DEB80}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Asthma </span> Asthma is a disease of diffuse airway inflammation caused by a variety of triggering stimuli resulting in partially or completely reversible bronchoconstriction. Symptoms and signs include dyspnea... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), especially for high-risk patients. Beta-blockers reduce heart rate, arterial pressure, and contractility, thereby reducing cardiac workload and oxygen demand. Infarct size largely determines cardiac performance after recovery. Oral beta-blockers given within the first few hours improve prognosis by reducing infarct size, recurrence rate, incidence of ventricular fibrillation, and mortality risk (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v27854180" data-toggle="tooltip" title="Beta-blocker reference" data-id="d5a18397-0677-4fca-b183-503a75d0afb1" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">1</a><span id="d5a18397-0677-4fca-b183-503a75d0afb1" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v27854180"> <span class="tooltip-content"> <span class="tooltip-heading"> Beta-blocker reference </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v27854178" class="anchor"></span><div class="para"> <p>Heart rate and BP must be carefully monitored during treatment with beta-blockers. Dosage is reduced if bradycardia or hypotension develops. Excessive adverse effects may be reversed by infusion of the beta-adrenergic agonist <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>isoproterenol</span> 1 to 5 mcg/minute.</p></div> <section id="v27854179" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v27854180" class="anchor"></span> Beta-blocker reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v27854183" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/16271643">Chen ZM, Pan HC, Chen YP, et al.</a> Early intravenous then oral <span class="genericDrug" data-showrollover="false">metoprolol</span> in 45,852 patients with acute myocardial infarction: randomised placebo controlled trial. <i>Lancet</i> 366:1622–1632, 2005.</p></div></li></ul></div> </div> </section> </div> </section> <section id="v27854186" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v27854187" class="anchor"></span> Nitrates </h2> <div class="topic__content"> <span id="v27854190" class="anchor"></span><div class="para"> <p> A short-acting nitrate, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span>, is used to reduce cardiac workload in selected patients. <span class="genericDrug" data-showrollover="false">Nitroglycerin</span> dilates veins, arteries, and arterioles, reducing left ventricular preload and afterload. As a result, myocardial oxygen demand is reduced, lessening ischemia.</p></div><span id="v27854191" class="anchor"></span><div class="para"> <p>IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span> is recommended during the first 24 to 48 hours for patients with <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="9a44f670-3aa2-4ff3-9318-32128015de89" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="9a44f670-3aa2-4ff3-9318-32128015de89" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span>, large anterior myocardial infarction, persistent chest discomfort, or <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html" data-toggle="tooltip" title="Hypertension" data-id="dcff5179-1ee1-4d20-9d12-ce5183516409" data-itemid="b9a25e4f-9bea-42de-8ee8-16e867adc0b5">hypertension</a><span id="dcff5179-1ee1-4d20-9d12-ce5183516409" class="d-none xref"> <span class="tooltip-container"> <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypertension </span> Hypertension is sustained elevation of resting systolic blood pressure (≥ 130 mm Hg), diastolic blood pressure (≥ 80 mm Hg), or both. Hypertension with no known cause (primary; formerly, essential... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/1/5/515-left-ventricular-hypertrophy-on-ekg-s108-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hypertension" loading="lazy"> </span> </a> </span> </span>. BP should not be reduced to <span class='symbol'>&lt</span> 110 to 120 mm Hg systolic; patients who remain symptomatic at that BP should have emergency PCI rather than further BP reduction.</p></div><span id="v27854192" class="anchor"></span><div class="para"> <p>Longer use may benefit patients with recurrent chest pain or persistent pulmonary congestion. In high-risk patients, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span> given in the first few hours reduces infarct size and short-term and possibly long-term mortality risk. <span class="genericDrug" data-showrollover="false">Nitroglycerin</span> is not routinely given to low-risk patients with uncomplicated myocardial infarction.</p></div> </div> </section> <section id="v27854193" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v27854194" class="anchor"></span> Fibrinolytics </h2> <div class="topic__content"> <span id="v27854195" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tenecteplase</span> (TNK), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span> (rTPA), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>reteplase</span> (rPA), streptokinase, and anistreplase (anisoylated <span class="genericDrug" data-showrollover="false">plasminogen</span> activator complex—APSAC), all given IV, are <span class="genericDrug" data-showrollover="false">plasminogen</span> activators. They convert single-chain <span class="genericDrug" data-showrollover="false">plasminogen</span> to double-chain <span class="genericDrug" data-showrollover="false">plasminogen</span>, which has fibrinolytic activity. They have different characteristics and dosing regimens (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"264a5913-aa83-4ff2-bf45-96524eba3735","Title":"IV%20Fibrinolytic%20Therapies","ShareUrlTitle":"iv-fibrinolytic-therapies","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v27854207","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3E%20IV%20Fibrinolytic%20Therapies%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>) and are appropriate only for selected patients with <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852672" data-toggle="tooltip" title="Infarct extent" data-id="6a6bb722-f148-4b3a-a4ff-62077a7062d8" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">STEMI</a><span id="6a6bb722-f148-4b3a-a4ff-62077a7062d8" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852672"> <span class="tooltip-content"> <span class="tooltip-heading"> Infarct extent </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infarct extent" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v27854198" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tenecteplase</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>reteplase</span> are recommended most often because of their simplicity of administration; <span class="genericDrug" data-showrollover="false">tenecteplase</span> is given as a single bolus over 5 seconds and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>reteplase</span> as a double bolus 30 minutes apart. Administration time and medication errors are reduced compared with other fibrinolytics. <span class="genericDrug" data-showrollover="false">Tenecteplase</span>, like <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span>, has an intermediate risk of intracranial hemorrhage and has a higher rate of recanalization than other fibrinolytics. <span class="genericDrug" data-showrollover="false">Reteplase</span> has the highest risk of intracranial hemorrhage and a recanalization rate similar to that of <span class="genericDrug" data-showrollover="false">tenecteplase</span>, and it is expensive.</p></div><span id="v27854199" class="anchor"></span><div class="para"> <p>Streptokinase (not available in the United States) may induce allergic reactions, especially if it has been used previously, and must be given by infusion over 30 to 60 minutes; however, it has a low incidence of intracerebral hemorrhage and is relatively inexpensive. Anistreplase, related to <span class="genericDrug" data-showrollover="false">streptokinase</span>, is similarly allergenic and slightly more expensive but can be given as a single bolus. Neither drug requires concomitant <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> use. For both, recanalization rate is lower than that with other <span class="genericDrug" data-showrollover="false">plasminogen</span> activators. Because of the possibility of allergic reactions, patients who previously received streptokinase or anistreplase are not given that drug again.</p></div><span id="v27854204" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alteplase</span> is given in an accelerated or front-loaded dosage over 90 minutes. <span class="genericDrug" data-showrollover="false">Alteplase</span> with concomitant IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> improves patency, is nonallergenic, and has a higher recanalization rate than other fibrinolytics.</p></div> <span id="v27854206"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v27854208"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"264a5913-aa83-4ff2-bf45-96524eba3735","Title":"IV%20Fibrinolytic%20Therapies","ShareUrlTitle":"iv-fibrinolytic-therapies","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v27854207","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"IV%20Fibrinolytic%20Therapies","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="264a5913-aa83-4ff2-bf45-96524eba3735"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '264a5913-aa83-4ff2-bf45-96524eba3735' }, async: true, success: function (data) { $('#264a5913-aa83-4ff2-bf45-96524eba3735').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <div class="inlinemedia-component " data-ko-rebind="v27854200" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/IntracranialBleedingRiskThrombolytics.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"2c830a78-26a1-47c7-af59-b6be1b4835f1","Title":"Intracranial Bleeding Risk from Thrombolytic Therapy of MI","ShareUrlTitle":"intracranial-bleeding-risk-from-thrombolytic-therapy-of-mi","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <section id="v41360648" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v41360649" class="anchor"></span> Contraindications to fibrinolytic therapy </h3> <div class="topic__content"> <span id="v41360650" class="anchor"></span><div class="para"> <p>There are many absolute and relative contraindications to fibrinolytic therapy. In general, the presence of active bleeding or a condition where bleeding would be life-threatening is an absolute contraindication. The contraindications to fibrinolytic therapy are listed in the table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"66a3b179-040d-4ffb-9f1d-2fda4899857a","Title":"Contraindications%20to%20Fibrinolytic%20Therapy","ShareUrlTitle":"contraindications-to-fibrinolytic-therapy","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v41360653","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EContraindications%20to%20Fibrinolytic%20Therapy%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>.</p></div> <span id="v41360652"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v41360654"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"66a3b179-040d-4ffb-9f1d-2fda4899857a","Title":"Contraindications%20to%20Fibrinolytic%20Therapy","ShareUrlTitle":"contraindications-to-fibrinolytic-therapy","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v41360653","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Contraindications%20to%20Fibrinolytic%20Therapy","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="66a3b179-040d-4ffb-9f1d-2fda4899857a"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '66a3b179-040d-4ffb-9f1d-2fda4899857a' }, async: true, success: function (data) { $('#66a3b179-040d-4ffb-9f1d-2fda4899857a').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> </div> </section> <section id="v27859162" class="topic__section FHead"> <h2 id="" class="topic__header--section" data-originaltitle="Other Medications"> <span id="v27859163" class="anchor"></span> Other Medications for Acute Coronary Syndromes </h2> <div class="topic__content"> <span id="v27859164" class="anchor"></span><div class="para"> <p><b>Angiotensin-converting enzyme (ACE) inhibitors</b> reduce mortality risk in patients with myocardial infarction, especially in those with anterior infarction, heart failure, or tachycardia. The greatest benefit occurs in the highest-risk patients early during convalescence. ACE inhibitors are given <span class='symbol'>></span> 24 hours after thrombolysis stabilization and, because of continued beneficial effect, may be prescribed long-term.</p></div><span id="v27859166" class="anchor"></span><div class="para"> <p><b><span class="genericDrug" data-showrollover="false">Angiotensin II</span> receptor blockers</b> (ARBs) may be an effective alternative for patients who cannot tolerate ACE inhibitors (eg, because of cough). They are not first-line treatment after myocardial infarction. Contraindications include hypotension, kidney failure, bilateral renal artery stenosis, and known allergy.</p></div><span id="v27859168" class="anchor"></span><div class="para"> <p><b>Statins</b> (HMG-CoA reductase inhibitors) have long been used for prevention of coronary artery disease and acute coronary syndromes, but there is now increasing evidence that they also have short-term benefits, such as stabilizing plaque, reversing endothelial dysfunction, decreasing thrombogenicity, and reducing inflammation. Thus, all patients without contraindications (eg, statin-induced myopathy, liver dysfunction) to therapy should receive a statin at the maximally tolerated dose as early as possible following ACS regardless of their serum lipid levels (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v88135974" data-toggle="tooltip" title="Other medications references" data-id="30030280-0116-4d76-942f-3c6568cef68d" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">1</a><span id="30030280-0116-4d76-942f-3c6568cef68d" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v88135974"> <span class="tooltip-content"> <span class="tooltip-heading"> Other medications references </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v49484476" class="anchor"></span><div class="para"> <p><b>PCSK-9 inhibitors</b> (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>evolocumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alirocumab</span>) are used for patients not at target low-density lipoprotein cholesterol levels. They are used alone or in combination with other lipid-lowering therapies (eg, statins, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span>) for the treatment of adults with primary hyperlipidemia (including familial hypercholesterolemia). </p></div><span id="v88135971" class="anchor"></span><div class="para"> <p>In patients who have had an MI, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>icosapent ethyl</span> is also used to reduce lipid levels (<a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v88135974" data-toggle="tooltip" title="Other medications references" data-id="2a2aea46-3a58-4b0f-ba62-36a68410dcee" data-itemid="fbc4b0ec-6fa3-474b-9ccf-5de368a19e06">2</a><span id="2a2aea46-3a58-4b0f-ba62-36a68410dcee" class="d-none xref"> <span class="tooltip-container"> <a href="./{FBC4B0EC-6FA3-474B-9CCF-5DE368A19E06}.html#v88135974"> <span class="tooltip-content"> <span class="tooltip-heading"> Other medications references </span> Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div> <section id="v88135973" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v88135974" class="anchor"></span> Other medications references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v88135977" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29371200/">Wang WT, Hellkamp A, Doll JA, et al</a>. Lipid Testing and Statin Dosing After Acute Myocardial Infarction. <i>J Am Heart Assoc</i> 2018;7(3):e006460. Published 2018 Jan 25. doi:10.1161/JAHA.117.006460</p></div></li><li class="topic__listitem"><span id="v88135980" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35483753/">Gaba P, Bhatt DL, Steg PG, et al</a>. Prevention of Cardiovascular Events and Mortality With <span class="genericDrug" data-showrollover="false">Icosapent Ethyl</span> in Patients With Prior Myocardial Infarction. <i>J Am Coll Cardiol</i> 2022;79(17):1660-1671. doi:10.1016/j.jacc.2022.02.035</p></div></li></ul></div> </div> </section> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="MM1108">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: 'MM1108',
 title: 'Medications for Acute Coronary Syndromes',
 itemGuid: 'fbc4b0ec-6fa3-474b-9ccf-5de368a19e06'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{5D5ADB45-ADE9-45A0-9E42-288C121E0C48}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Complications of Acute Coronary Syndromes</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{528946F8-04D5-4DB7-B03B-1A97B7391290}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Overview of Revascularization for Acute Coronary Syndromes</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="fda69beb-a51a-42b5-974a-9d621a388b03_mobile" usemap="#fda69beb-a51a-42b5-974a-9d621a388b03_mobile" width="326" height="90">
 <map name="fda69beb-a51a-42b5-974a-9d621a388b03_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="fda69beb-a51a-42b5-974a-9d621a388b03_tablet" usemap="#fda69beb-a51a-42b5-974a-9d621a388b03_tablet" width="326" height="90">
 <map name="fda69beb-a51a-42b5-974a-9d621a388b03_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="fda69beb-a51a-42b5-974a-9d621a388b03_desktop" usemap="#fda69beb-a51a-42b5-974a-9d621a388b03_desktop" width="326" height="90">
 <map name="fda69beb-a51a-42b5-974a-9d621a388b03_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd01
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="FBC4B0EC6FA3474B9CCF5DE368A19E06">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v41360653'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v41360654"></span> <div class="TableHalfPage" id="v41360653"> <h3 class="title">Contraindications to Fibrinolytic Therapy</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td rowspan="6"><span id="v41360661" class="anchor"></span><div class="para"> <p>Absolute contraindications</p></div></td><td><span id="v41360663" class="anchor"></span><div class="para"> <p>Aortic dissection</p></div></td></tr><tr class="even"><td><span id="v41360666" class="anchor"></span><div class="para"> <p>Previous hemorrhagic stroke (at any time)</p></div></td></tr><tr class="odd"><td><span id="v41360669" class="anchor"></span><div class="para"> <p>Previous ischemic stroke within 1 year</p></div></td></tr><tr class="even"><td><span id="v41360672" class="anchor"></span><div class="para"> <p>Active internal bleeding (not menses)</p></div></td></tr><tr class="odd"><td><span id="v41360675" class="anchor"></span><div class="para"> <p>Intracranial tumor</p></div></td></tr><tr class="even"><td><span id="v41360678" class="anchor"></span><div class="para"> <p>Pericarditis</p></div></td></tr><tr class="odd"><td rowspan="7"><span id="v41360681" class="anchor"></span><div class="para"> <p>Relative contraindications</p></div></td><td><span id="v41360683" class="anchor"></span><div class="para"> <p>Blood pressure <span class='symbol'>></span> 180/110 mm Hg after initial antihypertensive therapy</p></div></td></tr><tr class="even"><td><span id="v41360686" class="anchor"></span><div class="para"> <p>Trauma or major surgery within 4 weeks</p></div></td></tr><tr class="odd"><td><span id="v41360689" class="anchor"></span><div class="para"> <p>Active peptic ulcer</p></div></td></tr><tr class="even"><td><span id="v41360692" class="anchor"></span><div class="para"> <p>Pregnancy</p></div></td></tr><tr class="odd"><td><span id="v41360695" class="anchor"></span><div class="para"> <p>Bleeding diathesis</p></div></td></tr><tr class="even"><td><span id="v41360698" class="anchor"></span><div class="para"> <p>Noncompressible vascular puncture</p></div></td></tr><tr class="odd"><td><span id="v41360701" class="anchor"></span><div class="para"> <p>Current anticoagulation (INR <span class='symbol'>></span> 2)</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v27854207'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v27854208"></span> <div class="TableFullPage" id="v27854207"> <h3 class="title">IV Fibrinolytic Therapies</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v41360645" class="anchor"></span><div class="para"> <p>Medication</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v41360647" class="anchor"></span><div class="para"> <p>Circulating half-life (minutes)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v27854232" class="anchor"></span><div class="para"> <p>Concurrent <span class="genericDrug" data-showrollover="false">heparin</span></p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v27854235" class="anchor"></span><div class="para"> <p>Allergic reactions</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v27854250" class="anchor"></span><div class="para"> <p>Anistreplase</p></div></td><td><span id="v27854254" class="anchor"></span><div class="para"> <p>100</p></div></td><td><span id="v27854256" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v27854258" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="even"><td><span id="v27854261" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alteplase</span></p></div></td><td><span id="v27854265" class="anchor"></span><div class="para"> <p>6</p></div></td><td><span id="v27854267" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v27854269" class="anchor"></span><div class="para"> <p>Rare</p></div></td></tr><tr class="odd"><td><span id="v27854272" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Reteplase</span></p></div></td><td><span id="v27854276" class="anchor"></span><div class="para"> <p>13–16</p></div></td><td><span id="v27854278" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v27854280" class="anchor"></span><div class="para"> <p>Rare</p></div></td></tr><tr class="even"><td><span id="v49362171" class="anchor"></span><div class="para"> <p>Streptokinase (not available in the United States)</p></div></td><td><span id="v49362175" class="anchor"></span><div class="para"> <p>20</p></div></td><td><span id="v49362177" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v49362179" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="odd"><td><span id="v27854283" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tenecteplase</span></p></div></td><td><span id="v27854292" class="anchor"></span><div class="para"> <p>Initial half-life of 20–24 minutes; terminal phase half-life of 90–130 minutes</p></div></td><td><span id="v27854294" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v27854296" class="anchor"></span><div class="para"> <p>Rare</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v88176366'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v88176367"></span> <div class="TableFullPage" id="v88176366"> <h3 class="title">Medications for Coronary Artery Disease*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v88176376" class="anchor"></span><div class="para"> <p>Medication</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v88176379" class="anchor"></span><div class="para"> <p>Dosage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v88176382" class="anchor"></span><div class="para"> <p>Use</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176408" class="anchor"></span><div class="para"> <p>Angiotensin-converting enzyme (ACE) inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v88176411" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Benazepril</span></p></div><span id="v88176412" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Captopril</span></p></div><span id="v88176413" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Enalapril</span> </p></div><span id="v88176414" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fosinopril</span></p></div><span id="v88176415" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lisinopril</span></p></div><span id="v88176416" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Moexipril</span></p></div><span id="v88176417" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Perindopril</span></p></div><span id="v88176418" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinapril</span></p></div><span id="v88176419" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ramipril</span></p></div><span id="v88176420" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trandolapril</span></p></div></td><td><span id="v88176422" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td><span id="v88176424" class="anchor"></span><div class="para"> <p>All patients with CAD, especially those with large infarctions, renal insufficiency, <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="30e2fd4d-da63-4969-b287-3d70ba34c40a" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="30e2fd4d-da63-4969-b287-3d70ba34c40a" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span>, <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html" data-toggle="tooltip" title="Hypertension" data-id="742922e3-5515-4562-b94d-13dcf275fdcc" data-itemid="b9a25e4f-9bea-42de-8ee8-16e867adc0b5">hypertension</a><span id="742922e3-5515-4562-b94d-13dcf275fdcc" class="d-none xref"> <span class="tooltip-container"> <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypertension </span> Hypertension is sustained elevation of resting systolic blood pressure (≥ 130 mm Hg), diastolic blood pressure (≥ 80 mm Hg), or both. Hypertension with no known cause (primary; formerly, essential... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/5/1/5/515-left-ventricular-hypertrophy-on-ekg-s108-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hypertension" loading="lazy"> </span> </a> </span> </span>, or <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="ce6bf47d-3c42-4ab0-aa0f-84e4641d660b" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes</a><span id="ce6bf47d-3c42-4ab0-aa0f-84e4641d660b" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div><span id="v88176428" class="anchor"></span><div class="para"> <p>Contraindications include hypotension, hyperkalemia, bilateral renal artery stenosis, pregnancy, and known allergy</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176432" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Angiotensin II</span> receptor blockers (ARBs)</p></div></p></td></tr><tr class="even"><td><span id="v88176436" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Candesartan</span></p></div><span id="v88176437" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Eprosartan</span></p></div><span id="v88176438" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Irbesartan</span></p></div><span id="v88176439" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Losartan</span></p></div><span id="v88176440" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Olmesartan</span></p></div><span id="v88176441" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Telmisartan</span></p></div><span id="v88176442" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Valsartan</span></p></div></td><td><span id="v88176444" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td><span id="v88176446" class="anchor"></span><div class="para"> <p>An effective alternative for patients who cannot tolerate ACE inhibitors (eg, because of cough); currently, not first-line treatment after MI</p></div><span id="v88176447" class="anchor"></span><div class="para"> <p>Contraindications include hypotension, hyperkalemia, bilateral renal artery stenosis, pregnancy, and known allergy</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176451" class="anchor"></span><div class="para"> <p>Anticoagulants: Direct-acting oral anticoagulants‡</p></div></p></td></tr><tr class="even"><td><span id="v88176454" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v88176456" class="anchor"></span><div class="para"> <p>5 mg orally twice a day</p></div></td><td rowspan="4"><span id="v88176458" class="anchor"></span><div class="para"> <p>May be useful long-term in patients with non-valvular <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html" data-toggle="tooltip" title="Atrial Fibrillation" data-id="8d18d8a6-20b3-4e51-9020-b3598fc8ee53" data-itemid="3118c057-fb1f-4aa1-8b87-c346cbc408c3">atrial fibrillation</a><span id="8d18d8a6-20b3-4e51-9020-b3598fc8ee53" class="d-none xref"> <span class="tooltip-container"> <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atrial Fibrillation </span> Atrial fibrillation is a rapid, irregularly irregular atrial rhythm. Symptoms include palpitations and sometimes weakness, effort intolerance, dyspnea, and presyncope. Atrial thrombi may form... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v88176462" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v88176464" class="anchor"></span><div class="para"> <p>150 mg orally twice a day (or 110–150 mg orally twice a day for patients also taking P2Y12 inhibitors)</p></div></td></tr><tr class="even"><td><span id="v88176467" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v88176469" class="anchor"></span><div class="para"> <p>60 mg orally once a day</p></div></td></tr><tr class="odd"><td><span id="v88176472" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v88176474" class="anchor"></span><div class="para"> <p>20 mg orally once a day (or 15 mg orally once a day for patients also taking P2Y12 inhibitors)</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176478" class="anchor"></span><div class="para"> <p>Anticoagulants: Direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v88176482" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Argatroban</span></p></div></td><td><span id="v88176484" class="anchor"></span><div class="para"> <p>350 mcg/kg (IV bolus) followed by 25 mcg/kg/minute (IV infusion)</p></div></td><td rowspan="2"><span id="v88176486" class="anchor"></span><div class="para"> <p>As an alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> in patients with ACS and a known or suspected history of <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="08f16b76-5d33-4d7b-a3d3-c3f0c5f43d02" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="08f16b76-5d33-4d7b-a3d3-c3f0c5f43d02" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v88176490" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bivalirudin</span></p></div></td><td><span id="v88176492" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176496" class="anchor"></span><div class="para"> <p>Anticoagulants: <span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v88176500" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fondaparinux</span></p></div></td><td><span id="v88176502" class="anchor"></span><div class="para"> <p>2.5 mg subcutaneously every 24 hours</p></div></td><td><span id="v88176504" class="anchor"></span><div class="para"> <p>As an alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> in patients with ACS and a known or suspected history of <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="f10703df-afb9-4d2c-8749-8084436d57e9" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="f10703df-afb9-4d2c-8749-8084436d57e9" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176509" class="anchor"></span><div class="para"> <p>Anticoagulants: Low molecular weight <span class="genericDrug" data-showrollover="false">heparins</span></p></div></p></td></tr><tr class="even"><td><span id="v88176513" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dalteparin</span></p></div><span id="v88176514" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Enoxaparin</span>¶</p></div><span id="v88176515" class="anchor"></span><div class="para"> <p>Tinzaparin</p></div></td><td><span id="v88176517" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td><span id="v88176519" class="anchor"></span><div class="para"> <p>Patients with <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html" data-toggle="tooltip" title="Unstable Angina" data-id="33dc9015-a650-4ede-aade-dfc2100d1506" data-itemid="f5554f32-c171-4894-9a7d-5bc591853560">unstable angina</a><span id="33dc9015-a650-4ede-aade-dfc2100d1506" class="d-none xref"> <span class="tooltip-container"> <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Unstable Angina </span> Unstable angina results from acute obstruction of a coronary artery without myocardial infarction. Symptoms include chest discomfort with or without dyspnea, nausea, and diaphoresis. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> or <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660" data-toggle="tooltip" title="Infarct extent" data-id="81b38685-8c09-4b82-9a6d-b604730ca74b" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">NSTEMI</a><span id="81b38685-8c09-4b82-9a6d-b604730ca74b" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660"> <span class="tooltip-content"> <span class="tooltip-heading"> Infarct extent </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infarct extent" loading="lazy"> </span> </a> </span> </span></p></div><span id="v88176522" class="anchor"></span><div class="para"> <p>Patients <span class='symbol'></span> 75 years receiving <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tenecteplase</span></p></div><span id="v88176523" class="anchor"></span><div class="para"> <p>Almost all patients with <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660" data-toggle="tooltip" title="Infarct extent" data-id="0bb6647c-0125-4133-b0e7-3a52f0c127f2" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">STEMI</a><span id="0bb6647c-0125-4133-b0e7-3a52f0c127f2" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660"> <span class="tooltip-content"> <span class="tooltip-heading"> Infarct extent </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infarct extent" loading="lazy"> </span> </a> </span> </span> as an alternative to unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> (unless PCI is indicated and can be done in <span class='symbol'></span> 90 minutes); drug continued until PCI or CABG is done or patient is discharged</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176529" class="anchor"></span><div class="para"> <p>Anticoagulants: Unfractionated <span class="genericDrug" data-showrollover="false">heparin</span></p></div></p></td></tr><tr class="even"><td><span id="v88176533" class="anchor"></span><div class="para"> <p>Unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></p></div></td><td><span id="v88176535" class="anchor"></span><div class="para"> <p><b>Patients with unstable angina or NSTEMI</b>: 60–70 units/kg IV (maximum, 5000 units; bolus), followed by 12–15 units/kg/hour (maximum, 1000 units/hour) for 48 hours or until PCI is complete</p></div><span id="v88176536" class="anchor"></span><div class="para"> <p><b>Patients with STEMI</b>: 60 units/kg IV (maximum, 4000 units; bolus) given when <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>reteplase</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tenecteplase</span> is started, then followed by 12 units/kg/hour (maximum, 1000 units/hour) for 48 hours or until PCI is complete</p></div></td><td><span id="v88176538" class="anchor"></span><div class="para"> <p>Patients with unstable angina or NSTEMI as an alternative to <span class="genericDrug" data-showrollover="false">enoxaparin</span></p></div><span id="v88176540" class="anchor"></span><div class="para"> <p>Patients who have STEMI and undergo urgent angiography and PCI or patients <span class='symbol'>></span> 75 years receiving <span class="genericDrug" data-showrollover="false">tenecteplase</span></p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176545" class="anchor"></span><div class="para"> <p>Anticoagulants: Vitamin K inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v88176548" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span></p></div></td><td><span id="v88176550" class="anchor"></span><div class="para"> <p>Oral dose adjusted to maintain INR of 2–3</p></div></td><td><span id="v88176552" class="anchor"></span><div class="para"> <p>Recommended for primary prevention in patients at high risk of systemic emboli (ie, with atrial fibrillation, mechanical heart valves, <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html" data-toggle="tooltip" title="Deep Venous Thrombosis (DVT)" data-id="914b69c5-d550-44ce-992c-ec83c190856b" data-itemid="40a030fa-c405-40db-867d-6853f28279be">venous thromboembolism</a><span id="914b69c5-d550-44ce-992c-ec83c190856b" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Deep Venous Thrombosis (DVT) </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Deep Venous Thrombosis (DVT)" loading="lazy"> </span> </a> </span> </span>, hypercoagulable disorders, or LV thrombus)</p></div><span id="v88176554" class="anchor"></span><div class="para"> <p>May be useful for primary prevention in patients with STEMI and anterior wall akinesis or dyskinesis if risk of bleeding is low</p></div><span id="v88176555" class="anchor"></span><div class="para"> <p>Reasonable for patients with asymptomatic mural thrombus</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176559" class="anchor"></span><div class="para"> <p>Antiplatelet agents</p></div></p></td></tr><tr class="even"><td><span id="v88176562" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span></p></div></td><td><span id="v88176564" class="anchor"></span><div class="para"> <p><b>For stable angina†:</b> 75 or 81 mg orally once a day (enteric-coated)</p></div><span id="v88176565" class="anchor"></span><div class="para"> <p><b>For ACS:</b> 160–325 mg orally chewed (not enteric-coated) on arrival at emergency department and once a day thereafter during hospitalization and 81 mg§ orally once a day long-term after discharge</p></div></td><td><span id="v88176567" class="anchor"></span><div class="para"> <p><b>For</b>All patients with CAD unless <span class="genericDrug" data-showrollover="false">aspirin</span> is not tolerated or is contraindicated; used long-term</p></div></td></tr><tr class="odd"><td><span id="v88176571" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clopidogrel</span> </p></div></td><td><span id="v88176573" class="anchor"></span><div class="para"> <p>75 mg orally once a day</p></div><span id="v88176574" class="anchor"></span><div class="para"> <p><b>For patients undergoing PCI:</b> 300–600 mg orally once, then 75 mg orally once a day for 1–12 months</p></div></td><td><span id="v88176576" class="anchor"></span><div class="para"> <p>Used with <span class="genericDrug" data-showrollover="false">aspirin</span> or, in patients who cannot tolerate <span class="genericDrug" data-showrollover="false">aspirin</span>, alone</p></div><span id="v88176579" class="anchor"></span><div class="para"> <p>For elective PCI, maintenance therapy required for at least 1 month for bare-metal stents and for at least 6–12 months for drug-eluting stents</p></div><span id="v88176580" class="anchor"></span><div class="para"> <p>For ACS, dual antiplatelet therapy (typically with <span class="genericDrug" data-showrollover="false">aspirin</span>) is recommended for at least 12 months (for any type of stent)</p></div></td></tr><tr class="even"><td><span id="v88176584" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prasugrel</span></p></div></td><td><span id="v88176586" class="anchor"></span><div class="para"> <p>60 mg orally once before PCI, followed by 10 mg orally once a day for 1–12 months</p></div></td><td><span id="v88176588" class="anchor"></span><div class="para"> <p>Only for patients with ACS undergoing PCI</p></div><span id="v88176589" class="anchor"></span><div class="para"> <p>Not used in combination with fibrinolytic therapy</p></div></td></tr><tr class="odd"><td><span id="v88176592" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ticagrelor</span></p></div></td><td><span id="v88176594" class="anchor"></span><div class="para"> <p><b>For patients undergoing PCI:</b> 180 mg orally once before the procedure, followed by 90 mg orally twice a day for 1–12 months</p></div></td><td><span id="v88176596" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v88176599" class="anchor"></span><div class="para"> <p>Ticlopidine</p></div></td><td><span id="v88176601" class="anchor"></span><div class="para"> <p>250 mg orally twice a day for 1–12 months</p></div></td><td><span id="v88176603" class="anchor"></span><div class="para"> <p>Rarely used routinely because <a href="./{544520E6-4014-4C0A-B5C5-4288FBF5EE6F}.html" data-toggle="tooltip" title="Neutropenia" data-id="5e06229f-5fb8-4ba2-bc32-1a106834f674" data-itemid="544520e6-4014-4c0a-b5c5-4288fbf5ee6f">neutropenia</a><span id="5e06229f-5fb8-4ba2-bc32-1a106834f674" class="d-none xref"> <span class="tooltip-container"> <a href="./{544520E6-4014-4C0A-B5C5-4288FBF5EE6F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Neutropenia </span> Neutropenia is a reduction in the blood neutrophil count. If it is severe, the risk and severity of bacterial and fungal infections increase. Focal symptoms of infection may be muted, but fever... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is a risk and white blood cell count must be monitored regularly</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176608" class="anchor"></span><div class="para"> <p>Beta-blockers</p></div></p></td></tr><tr class="even"><td><span id="v88176611" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atenolol</span></p></div></td><td><span id="v88176613" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td rowspan="4"><span id="v88176615" class="anchor"></span><div class="para"> <p>All patients with ACS, unless a beta-blocker is not tolerated or is contraindicated, especially high-risk patients; used long-term </p></div><span id="v88176616" class="anchor"></span><div class="para"> <p>Intravenous beta-blockers may be used in patients with ongoing <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html" data-toggle="tooltip" title="Chest Pain" data-id="17901976-3002-4b8f-9a32-23eaa4c83a91" data-itemid="6e62c870-06cb-4abd-ba63-466123930c4b">chest pain</a><span id="17901976-3002-4b8f-9a32-23eaa4c83a91" class="d-none xref"> <span class="tooltip-container"> <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chest Pain </span> Chest pain is a very common complaint. Many patients are well aware that it is a warning of potential life-threatening disorders and seek evaluation for minimal symptoms. Other patients, including... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> despite usual measures, or persistent tachycardia, or hypertension in patients with unstable angina and myocardial infarction. Caution is necessary in patients with hypotension or other evidence of hemodynamic instability.</p></div></td></tr><tr class="odd"><td><span id="v88176620" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bisoprolol</span></p></div></td><td><span id="v88176622" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even"><td><span id="v88176625" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carvedilol</span></p></div></td><td><span id="v88176627" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176630" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metoprolol</span></p></div></td><td><span id="v88176632" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176636" class="anchor"></span><div class="para"> <p>Calcium channel blockers</p></div></p></td></tr><tr class="odd"><td><span id="v88176639" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amlodipine</span></p></div></td><td><span id="v88176641" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td rowspan="5"><span id="v88176643" class="anchor"></span><div class="para"> <p>Patients with stable <a href="./{EAD663A1-8F93-4B72-881E-2BCEFEC7B069}.html" data-toggle="tooltip" title="Angina Pectoris" data-id="bb642903-562e-480a-9b5c-3d57725ca392" data-itemid="ead663a1-8f93-4b72-881e-2bcefec7b069">angina</a><span id="bb642903-562e-480a-9b5c-3d57725ca392" class="d-none xref"> <span class="tooltip-container"> <a href="./{EAD663A1-8F93-4B72-881E-2BCEFEC7B069}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Angina Pectoris </span> Angina pectoris is a clinical syndrome of precordial discomfort or pressure due to transient myocardial ischemia without infarction. It is typically precipitated by exertion or psychologic stress... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> if symptoms persist despite nitrates use or if nitrates are not tolerated</p></div></td></tr><tr class="even"><td><span id="v88176647" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Diltiazem</span> (extended-release)</p></div></td><td><span id="v88176649" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176652" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Felodipine</span></p></div></td><td><span id="v88176654" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even"><td><span id="v88176657" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nifedipine</span> (extended-release)</p></div></td><td><span id="v88176659" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176662" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Verapamil</span> (extended-release)</p></div></td><td><span id="v88176664" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176668" class="anchor"></span><div class="para"> <p>Glycoprotein IIb/IIIa inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v88176671" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abciximab</span></p></div></td><td><span id="v88176673" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td rowspan="3"><span id="v88176675" class="anchor"></span><div class="para"> <p>Some patients with ACS, particularly those who are having PCI with stent placement and high-risk patients with unstable angina or NSTEMI and large thrombus burden</p></div><span id="v88176676" class="anchor"></span><div class="para"> <p>Therapy started during PCI and continued for 6–24 hours thereafter</p></div></td></tr><tr class="even"><td><span id="v88176679" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Eptifibatide</span></p></div></td><td><span id="v88176681" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176684" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tirofiban</span></p></div></td><td><span id="v88176686" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176690" class="anchor"></span><div class="para"> <p>Nitrates: Short acting</p></div></p></td></tr><tr class="odd"><td><span id="v88176693" class="anchor"></span><div class="para"> <p>Sublingual <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span> (tablet or spray)</p></div></td><td><span id="v88176695" class="anchor"></span><div class="para"> <p>0.3–0.6 mg every 4–5 minutes up to 3 doses</p></div></td><td><span id="v88176697" class="anchor"></span><div class="para"> <p>All patients for immediate relief of <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html" data-toggle="tooltip" title="Chest Pain" data-id="f896ff97-ea6b-4d81-ab60-3331ef560425" data-itemid="6e62c870-06cb-4abd-ba63-466123930c4b">chest pain</a><span id="f896ff97-ea6b-4d81-ab60-3331ef560425" class="d-none xref"> <span class="tooltip-container"> <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chest Pain </span> Chest pain is a very common complaint. Many patients are well aware that it is a warning of potential life-threatening disorders and seek evaluation for minimal symptoms. Other patients, including... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>; used as needed</p></div></td></tr><tr class="even"><td><span id="v88176701" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span> as continuous IV drip</p></div></td><td><span id="v88176703" class="anchor"></span><div class="para"> <p>Started at 5 mcg/minute and increased 2.5–5.0 mcg every few minutes until required response occurs</p></div></td><td><span id="v88176705" class="anchor"></span><div class="para"> <p>Selected patients with ACS:</p></div><span id="v88176706" class="anchor"></span><div class="para"> <p>During the first 24 to 48 hours, those with <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="442ccb88-caf6-423b-963f-b67497afe908" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="442ccb88-caf6-423b-963f-b67497afe908" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span> (unless hypotension is present), large anterior <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="c2c88780-abef-4d94-8c5b-4cc9866753ad" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">myocardial infarction</a><span id="c2c88780-abef-4d94-8c5b-4cc9866753ad" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span>, persistent angina, or hypertension (BP is reduced by 10–20 mm Hg but not to <span class='symbol'></span> 80–90 mm Hg systolic)</p></div><span id="v88176709" class="anchor"></span><div class="para"> <p>For longer use, patients with recurrent angina or persistent pulmonary congestion</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176713" class="anchor"></span><div class="para"> <p>Nitrates: Long acting</p></div></p></td></tr><tr class="even"><td><span id="v88176716" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide dinitrate</span></p></div></td><td><span id="v88176718" class="anchor"></span><div class="para"> <p>10–20 mg orally 3 times a day; can be increased to 40 mg 3 times a day</p></div></td><td rowspan="6"><span id="v88176720" class="anchor"></span><div class="para"> <p>Patients who have unstable angina or persistent severe angina and continue to have anginal symptoms after the beta-blocker dose is maximized</p></div><span id="v88176721" class="anchor"></span><div class="para"> <p>A nitrate-free period of about 8–10 hours (typically at night) recommended to avoid tolerance (specific drugs recommend different durations of nitrate-free period)</p></div></td></tr><tr class="odd"><td><span id="v88176724" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide dinitrate</span> (sustained-release)</p></div></td><td><span id="v88176726" class="anchor"></span><div class="para"> <p>40–80 mg orally twice a day (typically given at 8 AM and 2 PM)</p></div></td></tr><tr class="even"><td><span id="v88176729" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide mononitrate</span></p></div></td><td><span id="v88176731" class="anchor"></span><div class="para"> <p>20 mg orally twice a day, with 7 hours between 1st and 2nd doses</p></div></td></tr><tr class="odd"><td><span id="v88176734" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide mononitrate</span> (sustained-release)</p></div></td><td><span id="v88176736" class="anchor"></span><div class="para"> <p>30 or 60 mg orally once a day, increased to 120 mg or, rarely, 240 mg</p></div></td></tr><tr class="even"><td><span id="v88176739" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span> patches</p></div></td><td><span id="v88176741" class="anchor"></span><div class="para"> <p>0.2–0.8 mg/hour applied between 6:00 and 9:00 AM and removed 12–14 hours later to avoid tolerance</p></div></td></tr><tr class="odd"><td><span id="v88176744" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span> ointment 2% preparation (15 mg/2.5 cm)</p></div></td><td><span id="v88176746" class="anchor"></span><div class="para"> <p>1.25 cm spread evenly over upper torso or arms every 6 to 8 hours and covered with plastic, increased to 7.5 cm as tolerated, and removed for 8–12 hours each day to avoid tolerance</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176750" class="anchor"></span><div class="para"> <p>Opioids</p></div></p></td></tr><tr class="odd"><td><span id="v88176753" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Morphine</span></p></div></td><td><span id="v88176755" class="anchor"></span><div class="para"> <p>2–4 mg IV, repeated as needed</p></div></td><td><span id="v88176757" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Morphine</span> should be used judiciously (eg, if <span class="genericDrug" data-showrollover="false">nitroglycerin</span> is contraindicated or if patient has symptoms despite maximal doses of <span class="genericDrug" data-showrollover="false">nitroglycerin</span>) given a possible increase in mortality as well as attenuation of P2Y12 receptor inhibitor activity </p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176764" class="anchor"></span><div class="para"> <p>PCSK-9 inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v88176767" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alirocumab</span></p></div></td><td><span id="v88176769" class="anchor"></span><div class="para"> <p>Initial dose: 75 mg subcutaneously, once every 2 weeks or 300 mg subcutaneously once every 4 weeks</p></div></td><td><span id="v88176771" class="anchor"></span><div class="para"> <p>For patients not at target LDL-C levels, used alone or in combination with other lipid-lowering therapies (eg, statins, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span>) for the treatment of adults with primary hyperlipidemia (including familial hypercholesterolemia)</p></div></td></tr><tr class="even"><td><span id="v88176774" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evolocumab</span></p></div></td><td><span id="v88176776" class="anchor"></span><div class="para"> <p>Initial dose for primary hyperlipidemia: 140 mg subcutaneously every 2 weeks or 420 mg subcutaneously once monthly</p></div></td><td><span id="v88176778" class="anchor"></span><div class="para"> <p>For patients not at target LDL-C levels, used alone or in combination with other lipid-lowering therapies (eg, statins, <span class="genericDrug" data-showrollover="false">ezetimibe</span>) for the treatment of adults with primary hyperlipidemia (including familial hypercholesterolemia)</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176783" class="anchor"></span><div class="para"> <p>Statins (HMG-CoA reductase inhibitors) </p></div></p></td></tr><tr class="even"><td><span id="v88176786" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span></p></div><span id="v88176787" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span></p></div><span id="v88176788" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span></p></div><span id="v88176789" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span></p></div><span id="v88176790" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span></p></div><span id="v88176791" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Simvastatin</span></p></div></td><td><span id="v88176793" class="anchor"></span><div class="para"> <p>Variable† (see <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v990176" data-toggle="tooltip" title="Treatment" data-id="c3b2d96c-f191-4397-a8a4-36894049c3e2" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">Dyslipidemia</a><span id="c3b2d96c-f191-4397-a8a4-36894049c3e2" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v990176"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment" loading="lazy"> </span> </a> </span> </span>)</p></div></td><td><span id="v88176796" class="anchor"></span><div class="para"> <p>Patients with CAD should be given maximally tolerated statin dose</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176800" class="anchor"></span><div class="para"> <p>Other medications</p></div></p></td></tr><tr class="even"><td><span id="v88176803" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ivabradine</span></p></div></td><td><span id="v88176805" class="anchor"></span><div class="para"> <p>5 mg orally twice a day, increased to 7.5 mg orally twice a day if needed</p></div></td><td><span id="v88176807" class="anchor"></span><div class="para"> <p>Inhibits sinus node </p></div><span id="v88176808" class="anchor"></span><div class="para"> <p>For symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm who cannot take beta-blockers</p></div><span id="v88176809" class="anchor"></span><div class="para"> <p>In combination with beta-blockers in patients inadequately controlled by beta-blocker alone and whose heart rate > 60 beats/minute</p></div></td></tr><tr class="odd"><td><span id="v88176812" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ranolazine</span></p></div></td><td><span id="v88176814" class="anchor"></span><div class="para"> <p>500 mg orally twice a day, increased to 1000 mg orally twice a day as needed</p></div></td><td><span id="v88176816" class="anchor"></span><div class="para"> <p>Patients in whom anginal symptoms continue despite treatment with other antianginal drugs</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v88176386" class="anchor"></span><div class="para"> <p>* Clinicians may use different combinations of medications depending on the type of coronary artery disease that is present.</p></div></td></tr><tr><td colspan="3"><span id="v88176389" class="anchor"></span><div class="para"> <p>† Refer to the manufacturer's prescribing information or a drug information database for specific dosing information.</p></div></td></tr><tr><td colspan="3"><span id="v88176392" class="anchor"></span><div class="para"> <p>‡ Lower doses of Direct-acting oral anticoagulants are sometimes used, based on patient-specific risk factors.</p></div></td></tr><tr><td colspan="3"><span id="v88176395" class="anchor"></span><div class="para"> <p>§ Higher doses of <span class="genericDrug" data-showrollover="false">aspirin</span> do not provide greater protection and increase risk of adverse effects.</p></div></td></tr><tr><td colspan="3"><span id="v88176399" class="anchor"></span><div class="para"> <p>¶ Of low molecular weight <span class="genericDrug" data-showrollover="false">heparins</span> (LMWHs), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span> is preferred.</p></div></td></tr><tr><td colspan="3"><span id="v88176403" class="anchor"></span><div class="para"> <p>ACS <span class='symbol'>=</span> acute coronary syndromes; BP <span class='symbol'>=</span> blood pressure; CABG <span class='symbol'>=</span> coronary artery bypass grafting; CAD <span class='symbol'>=</span> coronary artery disease; HMG <span class='symbol'>=</span> hydroxymethylglutaryl; INR <span class='symbol'>=</span> international normalized ratio; LDL-C <span class='symbol'>=</span> low-density lipoprotein cholesterol; LV <span class='symbol'>=</span> left ventricular; MI = myocardial infarction; NSTEMI <span class='symbol'>=</span> non–ST-segment elevation MI; PCI <span class='symbol'>=</span> percutaneous intervention; STEMI <span class='symbol'>=</span> ST-segment elevation MI.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v88176366'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v88176367"></span> <div class="TableFullPage" id="v88176366"> <h3 class="title">Medications for Coronary Artery Disease*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v88176376" class="anchor"></span><div class="para"> <p>Medication</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v88176379" class="anchor"></span><div class="para"> <p>Dosage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v88176382" class="anchor"></span><div class="para"> <p>Use</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176408" class="anchor"></span><div class="para"> <p>Angiotensin-converting enzyme (ACE) inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v88176411" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Benazepril</span></p></div><span id="v88176412" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Captopril</span></p></div><span id="v88176413" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Enalapril</span> </p></div><span id="v88176414" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fosinopril</span></p></div><span id="v88176415" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lisinopril</span></p></div><span id="v88176416" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Moexipril</span></p></div><span id="v88176417" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Perindopril</span></p></div><span id="v88176418" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinapril</span></p></div><span id="v88176419" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ramipril</span></p></div><span id="v88176420" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trandolapril</span></p></div></td><td><span id="v88176422" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td><span id="v88176424" class="anchor"></span><div class="para"> <p>All patients with CAD, especially those with large infarctions, renal insufficiency, <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="30e2fd4d-da63-4969-b287-3d70ba34c40a" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="30e2fd4d-da63-4969-b287-3d70ba34c40a" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span>, <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html" data-toggle="tooltip" title="Hypertension" data-id="742922e3-5515-4562-b94d-13dcf275fdcc" data-itemid="b9a25e4f-9bea-42de-8ee8-16e867adc0b5">hypertension</a><span id="742922e3-5515-4562-b94d-13dcf275fdcc" class="d-none xref"> <span class="tooltip-container"> <a href="./{B9A25E4F-9BEA-42DE-8EE8-16E867ADC0B5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypertension </span> Hypertension is sustained elevation of resting systolic blood pressure (≥ 130 mm Hg), diastolic blood pressure (≥ 80 mm Hg), or both. Hypertension with no known cause (primary; formerly, essential... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/5/1/5/515-left-ventricular-hypertrophy-on-ekg-s108-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hypertension" loading="lazy"> </span> </a> </span> </span>, or <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="ce6bf47d-3c42-4ab0-aa0f-84e4641d660b" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes</a><span id="ce6bf47d-3c42-4ab0-aa0f-84e4641d660b" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div><span id="v88176428" class="anchor"></span><div class="para"> <p>Contraindications include hypotension, hyperkalemia, bilateral renal artery stenosis, pregnancy, and known allergy</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176432" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Angiotensin II</span> receptor blockers (ARBs)</p></div></p></td></tr><tr class="even"><td><span id="v88176436" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Candesartan</span></p></div><span id="v88176437" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Eprosartan</span></p></div><span id="v88176438" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Irbesartan</span></p></div><span id="v88176439" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Losartan</span></p></div><span id="v88176440" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Olmesartan</span></p></div><span id="v88176441" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Telmisartan</span></p></div><span id="v88176442" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Valsartan</span></p></div></td><td><span id="v88176444" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td><span id="v88176446" class="anchor"></span><div class="para"> <p>An effective alternative for patients who cannot tolerate ACE inhibitors (eg, because of cough); currently, not first-line treatment after MI</p></div><span id="v88176447" class="anchor"></span><div class="para"> <p>Contraindications include hypotension, hyperkalemia, bilateral renal artery stenosis, pregnancy, and known allergy</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176451" class="anchor"></span><div class="para"> <p>Anticoagulants: Direct-acting oral anticoagulants‡</p></div></p></td></tr><tr class="even"><td><span id="v88176454" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v88176456" class="anchor"></span><div class="para"> <p>5 mg orally twice a day</p></div></td><td rowspan="4"><span id="v88176458" class="anchor"></span><div class="para"> <p>May be useful long-term in patients with non-valvular <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html" data-toggle="tooltip" title="Atrial Fibrillation" data-id="8d18d8a6-20b3-4e51-9020-b3598fc8ee53" data-itemid="3118c057-fb1f-4aa1-8b87-c346cbc408c3">atrial fibrillation</a><span id="8d18d8a6-20b3-4e51-9020-b3598fc8ee53" class="d-none xref"> <span class="tooltip-container"> <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atrial Fibrillation </span> Atrial fibrillation is a rapid, irregularly irregular atrial rhythm. Symptoms include palpitations and sometimes weakness, effort intolerance, dyspnea, and presyncope. Atrial thrombi may form... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v88176462" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v88176464" class="anchor"></span><div class="para"> <p>150 mg orally twice a day (or 110–150 mg orally twice a day for patients also taking P2Y12 inhibitors)</p></div></td></tr><tr class="even"><td><span id="v88176467" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v88176469" class="anchor"></span><div class="para"> <p>60 mg orally once a day</p></div></td></tr><tr class="odd"><td><span id="v88176472" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v88176474" class="anchor"></span><div class="para"> <p>20 mg orally once a day (or 15 mg orally once a day for patients also taking P2Y12 inhibitors)</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176478" class="anchor"></span><div class="para"> <p>Anticoagulants: Direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v88176482" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Argatroban</span></p></div></td><td><span id="v88176484" class="anchor"></span><div class="para"> <p>350 mcg/kg (IV bolus) followed by 25 mcg/kg/minute (IV infusion)</p></div></td><td rowspan="2"><span id="v88176486" class="anchor"></span><div class="para"> <p>As an alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> in patients with ACS and a known or suspected history of <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="08f16b76-5d33-4d7b-a3d3-c3f0c5f43d02" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="08f16b76-5d33-4d7b-a3d3-c3f0c5f43d02" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v88176490" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bivalirudin</span></p></div></td><td><span id="v88176492" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176496" class="anchor"></span><div class="para"> <p>Anticoagulants: <span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v88176500" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fondaparinux</span></p></div></td><td><span id="v88176502" class="anchor"></span><div class="para"> <p>2.5 mg subcutaneously every 24 hours</p></div></td><td><span id="v88176504" class="anchor"></span><div class="para"> <p>As an alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> in patients with ACS and a known or suspected history of <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="f10703df-afb9-4d2c-8749-8084436d57e9" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="f10703df-afb9-4d2c-8749-8084436d57e9" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176509" class="anchor"></span><div class="para"> <p>Anticoagulants: Low molecular weight <span class="genericDrug" data-showrollover="false">heparins</span></p></div></p></td></tr><tr class="even"><td><span id="v88176513" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dalteparin</span></p></div><span id="v88176514" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Enoxaparin</span>¶</p></div><span id="v88176515" class="anchor"></span><div class="para"> <p>Tinzaparin</p></div></td><td><span id="v88176517" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td><span id="v88176519" class="anchor"></span><div class="para"> <p>Patients with <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html" data-toggle="tooltip" title="Unstable Angina" data-id="33dc9015-a650-4ede-aade-dfc2100d1506" data-itemid="f5554f32-c171-4894-9a7d-5bc591853560">unstable angina</a><span id="33dc9015-a650-4ede-aade-dfc2100d1506" class="d-none xref"> <span class="tooltip-container"> <a href="./{F5554F32-C171-4894-9A7D-5BC591853560}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Unstable Angina </span> Unstable angina results from acute obstruction of a coronary artery without myocardial infarction. Symptoms include chest discomfort with or without dyspnea, nausea, and diaphoresis. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> or <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660" data-toggle="tooltip" title="Infarct extent" data-id="81b38685-8c09-4b82-9a6d-b604730ca74b" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">NSTEMI</a><span id="81b38685-8c09-4b82-9a6d-b604730ca74b" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660"> <span class="tooltip-content"> <span class="tooltip-heading"> Infarct extent </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infarct extent" loading="lazy"> </span> </a> </span> </span></p></div><span id="v88176522" class="anchor"></span><div class="para"> <p>Patients <span class='symbol'></span> 75 years receiving <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tenecteplase</span></p></div><span id="v88176523" class="anchor"></span><div class="para"> <p>Almost all patients with <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660" data-toggle="tooltip" title="Infarct extent" data-id="0bb6647c-0125-4133-b0e7-3a52f0c127f2" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">STEMI</a><span id="0bb6647c-0125-4133-b0e7-3a52f0c127f2" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html#v27852660"> <span class="tooltip-content"> <span class="tooltip-heading"> Infarct extent </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infarct extent" loading="lazy"> </span> </a> </span> </span> as an alternative to unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> (unless PCI is indicated and can be done in <span class='symbol'></span> 90 minutes); drug continued until PCI or CABG is done or patient is discharged</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176529" class="anchor"></span><div class="para"> <p>Anticoagulants: Unfractionated <span class="genericDrug" data-showrollover="false">heparin</span></p></div></p></td></tr><tr class="even"><td><span id="v88176533" class="anchor"></span><div class="para"> <p>Unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></p></div></td><td><span id="v88176535" class="anchor"></span><div class="para"> <p><b>Patients with unstable angina or NSTEMI</b>: 60–70 units/kg IV (maximum, 5000 units; bolus), followed by 12–15 units/kg/hour (maximum, 1000 units/hour) for 48 hours or until PCI is complete</p></div><span id="v88176536" class="anchor"></span><div class="para"> <p><b>Patients with STEMI</b>: 60 units/kg IV (maximum, 4000 units; bolus) given when <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>reteplase</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tenecteplase</span> is started, then followed by 12 units/kg/hour (maximum, 1000 units/hour) for 48 hours or until PCI is complete</p></div></td><td><span id="v88176538" class="anchor"></span><div class="para"> <p>Patients with unstable angina or NSTEMI as an alternative to <span class="genericDrug" data-showrollover="false">enoxaparin</span></p></div><span id="v88176540" class="anchor"></span><div class="para"> <p>Patients who have STEMI and undergo urgent angiography and PCI or patients <span class='symbol'>></span> 75 years receiving <span class="genericDrug" data-showrollover="false">tenecteplase</span></p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176545" class="anchor"></span><div class="para"> <p>Anticoagulants: Vitamin K inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v88176548" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span></p></div></td><td><span id="v88176550" class="anchor"></span><div class="para"> <p>Oral dose adjusted to maintain INR of 2–3</p></div></td><td><span id="v88176552" class="anchor"></span><div class="para"> <p>Recommended for primary prevention in patients at high risk of systemic emboli (ie, with atrial fibrillation, mechanical heart valves, <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html" data-toggle="tooltip" title="Deep Venous Thrombosis (DVT)" data-id="914b69c5-d550-44ce-992c-ec83c190856b" data-itemid="40a030fa-c405-40db-867d-6853f28279be">venous thromboembolism</a><span id="914b69c5-d550-44ce-992c-ec83c190856b" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Deep Venous Thrombosis (DVT) </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Deep Venous Thrombosis (DVT)" loading="lazy"> </span> </a> </span> </span>, hypercoagulable disorders, or LV thrombus)</p></div><span id="v88176554" class="anchor"></span><div class="para"> <p>May be useful for primary prevention in patients with STEMI and anterior wall akinesis or dyskinesis if risk of bleeding is low</p></div><span id="v88176555" class="anchor"></span><div class="para"> <p>Reasonable for patients with asymptomatic mural thrombus</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176559" class="anchor"></span><div class="para"> <p>Antiplatelet agents</p></div></p></td></tr><tr class="even"><td><span id="v88176562" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span></p></div></td><td><span id="v88176564" class="anchor"></span><div class="para"> <p><b>For stable angina†:</b> 75 or 81 mg orally once a day (enteric-coated)</p></div><span id="v88176565" class="anchor"></span><div class="para"> <p><b>For ACS:</b> 160–325 mg orally chewed (not enteric-coated) on arrival at emergency department and once a day thereafter during hospitalization and 81 mg§ orally once a day long-term after discharge</p></div></td><td><span id="v88176567" class="anchor"></span><div class="para"> <p><b>For</b>All patients with CAD unless <span class="genericDrug" data-showrollover="false">aspirin</span> is not tolerated or is contraindicated; used long-term</p></div></td></tr><tr class="odd"><td><span id="v88176571" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clopidogrel</span> </p></div></td><td><span id="v88176573" class="anchor"></span><div class="para"> <p>75 mg orally once a day</p></div><span id="v88176574" class="anchor"></span><div class="para"> <p><b>For patients undergoing PCI:</b> 300–600 mg orally once, then 75 mg orally once a day for 1–12 months</p></div></td><td><span id="v88176576" class="anchor"></span><div class="para"> <p>Used with <span class="genericDrug" data-showrollover="false">aspirin</span> or, in patients who cannot tolerate <span class="genericDrug" data-showrollover="false">aspirin</span>, alone</p></div><span id="v88176579" class="anchor"></span><div class="para"> <p>For elective PCI, maintenance therapy required for at least 1 month for bare-metal stents and for at least 6–12 months for drug-eluting stents</p></div><span id="v88176580" class="anchor"></span><div class="para"> <p>For ACS, dual antiplatelet therapy (typically with <span class="genericDrug" data-showrollover="false">aspirin</span>) is recommended for at least 12 months (for any type of stent)</p></div></td></tr><tr class="even"><td><span id="v88176584" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prasugrel</span></p></div></td><td><span id="v88176586" class="anchor"></span><div class="para"> <p>60 mg orally once before PCI, followed by 10 mg orally once a day for 1–12 months</p></div></td><td><span id="v88176588" class="anchor"></span><div class="para"> <p>Only for patients with ACS undergoing PCI</p></div><span id="v88176589" class="anchor"></span><div class="para"> <p>Not used in combination with fibrinolytic therapy</p></div></td></tr><tr class="odd"><td><span id="v88176592" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ticagrelor</span></p></div></td><td><span id="v88176594" class="anchor"></span><div class="para"> <p><b>For patients undergoing PCI:</b> 180 mg orally once before the procedure, followed by 90 mg orally twice a day for 1–12 months</p></div></td><td><span id="v88176596" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v88176599" class="anchor"></span><div class="para"> <p>Ticlopidine</p></div></td><td><span id="v88176601" class="anchor"></span><div class="para"> <p>250 mg orally twice a day for 1–12 months</p></div></td><td><span id="v88176603" class="anchor"></span><div class="para"> <p>Rarely used routinely because <a href="./{544520E6-4014-4C0A-B5C5-4288FBF5EE6F}.html" data-toggle="tooltip" title="Neutropenia" data-id="5e06229f-5fb8-4ba2-bc32-1a106834f674" data-itemid="544520e6-4014-4c0a-b5c5-4288fbf5ee6f">neutropenia</a><span id="5e06229f-5fb8-4ba2-bc32-1a106834f674" class="d-none xref"> <span class="tooltip-container"> <a href="./{544520E6-4014-4C0A-B5C5-4288FBF5EE6F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Neutropenia </span> Neutropenia is a reduction in the blood neutrophil count. If it is severe, the risk and severity of bacterial and fungal infections increase. Focal symptoms of infection may be muted, but fever... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is a risk and white blood cell count must be monitored regularly</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176608" class="anchor"></span><div class="para"> <p>Beta-blockers</p></div></p></td></tr><tr class="even"><td><span id="v88176611" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atenolol</span></p></div></td><td><span id="v88176613" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td rowspan="4"><span id="v88176615" class="anchor"></span><div class="para"> <p>All patients with ACS, unless a beta-blocker is not tolerated or is contraindicated, especially high-risk patients; used long-term </p></div><span id="v88176616" class="anchor"></span><div class="para"> <p>Intravenous beta-blockers may be used in patients with ongoing <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html" data-toggle="tooltip" title="Chest Pain" data-id="17901976-3002-4b8f-9a32-23eaa4c83a91" data-itemid="6e62c870-06cb-4abd-ba63-466123930c4b">chest pain</a><span id="17901976-3002-4b8f-9a32-23eaa4c83a91" class="d-none xref"> <span class="tooltip-container"> <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chest Pain </span> Chest pain is a very common complaint. Many patients are well aware that it is a warning of potential life-threatening disorders and seek evaluation for minimal symptoms. Other patients, including... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> despite usual measures, or persistent tachycardia, or hypertension in patients with unstable angina and myocardial infarction. Caution is necessary in patients with hypotension or other evidence of hemodynamic instability.</p></div></td></tr><tr class="odd"><td><span id="v88176620" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bisoprolol</span></p></div></td><td><span id="v88176622" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even"><td><span id="v88176625" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carvedilol</span></p></div></td><td><span id="v88176627" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176630" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metoprolol</span></p></div></td><td><span id="v88176632" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176636" class="anchor"></span><div class="para"> <p>Calcium channel blockers</p></div></p></td></tr><tr class="odd"><td><span id="v88176639" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amlodipine</span></p></div></td><td><span id="v88176641" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td rowspan="5"><span id="v88176643" class="anchor"></span><div class="para"> <p>Patients with stable <a href="./{EAD663A1-8F93-4B72-881E-2BCEFEC7B069}.html" data-toggle="tooltip" title="Angina Pectoris" data-id="bb642903-562e-480a-9b5c-3d57725ca392" data-itemid="ead663a1-8f93-4b72-881e-2bcefec7b069">angina</a><span id="bb642903-562e-480a-9b5c-3d57725ca392" class="d-none xref"> <span class="tooltip-container"> <a href="./{EAD663A1-8F93-4B72-881E-2BCEFEC7B069}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Angina Pectoris </span> Angina pectoris is a clinical syndrome of precordial discomfort or pressure due to transient myocardial ischemia without infarction. It is typically precipitated by exertion or psychologic stress... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> if symptoms persist despite nitrates use or if nitrates are not tolerated</p></div></td></tr><tr class="even"><td><span id="v88176647" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Diltiazem</span> (extended-release)</p></div></td><td><span id="v88176649" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176652" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Felodipine</span></p></div></td><td><span id="v88176654" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even"><td><span id="v88176657" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nifedipine</span> (extended-release)</p></div></td><td><span id="v88176659" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176662" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Verapamil</span> (extended-release)</p></div></td><td><span id="v88176664" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176668" class="anchor"></span><div class="para"> <p>Glycoprotein IIb/IIIa inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v88176671" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abciximab</span></p></div></td><td><span id="v88176673" class="anchor"></span><div class="para"> <p>Variable†</p></div></td><td rowspan="3"><span id="v88176675" class="anchor"></span><div class="para"> <p>Some patients with ACS, particularly those who are having PCI with stent placement and high-risk patients with unstable angina or NSTEMI and large thrombus burden</p></div><span id="v88176676" class="anchor"></span><div class="para"> <p>Therapy started during PCI and continued for 6–24 hours thereafter</p></div></td></tr><tr class="even"><td><span id="v88176679" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Eptifibatide</span></p></div></td><td><span id="v88176681" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="odd"><td><span id="v88176684" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tirofiban</span></p></div></td><td><span id="v88176686" class="anchor"></span><div class="para"> <p>Variable†</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176690" class="anchor"></span><div class="para"> <p>Nitrates: Short acting</p></div></p></td></tr><tr class="odd"><td><span id="v88176693" class="anchor"></span><div class="para"> <p>Sublingual <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nitroglycerin</span> (tablet or spray)</p></div></td><td><span id="v88176695" class="anchor"></span><div class="para"> <p>0.3–0.6 mg every 4–5 minutes up to 3 doses</p></div></td><td><span id="v88176697" class="anchor"></span><div class="para"> <p>All patients for immediate relief of <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html" data-toggle="tooltip" title="Chest Pain" data-id="f896ff97-ea6b-4d81-ab60-3331ef560425" data-itemid="6e62c870-06cb-4abd-ba63-466123930c4b">chest pain</a><span id="f896ff97-ea6b-4d81-ab60-3331ef560425" class="d-none xref"> <span class="tooltip-container"> <a href="./{6E62C870-06CB-4ABD-BA63-466123930C4B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chest Pain </span> Chest pain is a very common complaint. Many patients are well aware that it is a warning of potential life-threatening disorders and seek evaluation for minimal symptoms. Other patients, including... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>; used as needed</p></div></td></tr><tr class="even"><td><span id="v88176701" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span> as continuous IV drip</p></div></td><td><span id="v88176703" class="anchor"></span><div class="para"> <p>Started at 5 mcg/minute and increased 2.5–5.0 mcg every few minutes until required response occurs</p></div></td><td><span id="v88176705" class="anchor"></span><div class="para"> <p>Selected patients with ACS:</p></div><span id="v88176706" class="anchor"></span><div class="para"> <p>During the first 24 to 48 hours, those with <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="442ccb88-caf6-423b-963f-b67497afe908" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="442ccb88-caf6-423b-963f-b67497afe908" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span> (unless hypotension is present), large anterior <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="c2c88780-abef-4d94-8c5b-4cc9866753ad" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">myocardial infarction</a><span id="c2c88780-abef-4d94-8c5b-4cc9866753ad" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span>, persistent angina, or hypertension (BP is reduced by 10–20 mm Hg but not to <span class='symbol'></span> 80–90 mm Hg systolic)</p></div><span id="v88176709" class="anchor"></span><div class="para"> <p>For longer use, patients with recurrent angina or persistent pulmonary congestion</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176713" class="anchor"></span><div class="para"> <p>Nitrates: Long acting</p></div></p></td></tr><tr class="even"><td><span id="v88176716" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide dinitrate</span></p></div></td><td><span id="v88176718" class="anchor"></span><div class="para"> <p>10–20 mg orally 3 times a day; can be increased to 40 mg 3 times a day</p></div></td><td rowspan="6"><span id="v88176720" class="anchor"></span><div class="para"> <p>Patients who have unstable angina or persistent severe angina and continue to have anginal symptoms after the beta-blocker dose is maximized</p></div><span id="v88176721" class="anchor"></span><div class="para"> <p>A nitrate-free period of about 8–10 hours (typically at night) recommended to avoid tolerance (specific drugs recommend different durations of nitrate-free period)</p></div></td></tr><tr class="odd"><td><span id="v88176724" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide dinitrate</span> (sustained-release)</p></div></td><td><span id="v88176726" class="anchor"></span><div class="para"> <p>40–80 mg orally twice a day (typically given at 8 AM and 2 PM)</p></div></td></tr><tr class="even"><td><span id="v88176729" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide mononitrate</span></p></div></td><td><span id="v88176731" class="anchor"></span><div class="para"> <p>20 mg orally twice a day, with 7 hours between 1st and 2nd doses</p></div></td></tr><tr class="odd"><td><span id="v88176734" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Isosorbide mononitrate</span> (sustained-release)</p></div></td><td><span id="v88176736" class="anchor"></span><div class="para"> <p>30 or 60 mg orally once a day, increased to 120 mg or, rarely, 240 mg</p></div></td></tr><tr class="even"><td><span id="v88176739" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span> patches</p></div></td><td><span id="v88176741" class="anchor"></span><div class="para"> <p>0.2–0.8 mg/hour applied between 6:00 and 9:00 AM and removed 12–14 hours later to avoid tolerance</p></div></td></tr><tr class="odd"><td><span id="v88176744" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nitroglycerin</span> ointment 2% preparation (15 mg/2.5 cm)</p></div></td><td><span id="v88176746" class="anchor"></span><div class="para"> <p>1.25 cm spread evenly over upper torso or arms every 6 to 8 hours and covered with plastic, increased to 7.5 cm as tolerated, and removed for 8–12 hours each day to avoid tolerance</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176750" class="anchor"></span><div class="para"> <p>Opioids</p></div></p></td></tr><tr class="odd"><td><span id="v88176753" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Morphine</span></p></div></td><td><span id="v88176755" class="anchor"></span><div class="para"> <p>2–4 mg IV, repeated as needed</p></div></td><td><span id="v88176757" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Morphine</span> should be used judiciously (eg, if <span class="genericDrug" data-showrollover="false">nitroglycerin</span> is contraindicated or if patient has symptoms despite maximal doses of <span class="genericDrug" data-showrollover="false">nitroglycerin</span>) given a possible increase in mortality as well as attenuation of P2Y12 receptor inhibitor activity </p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176764" class="anchor"></span><div class="para"> <p>PCSK-9 inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v88176767" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alirocumab</span></p></div></td><td><span id="v88176769" class="anchor"></span><div class="para"> <p>Initial dose: 75 mg subcutaneously, once every 2 weeks or 300 mg subcutaneously once every 4 weeks</p></div></td><td><span id="v88176771" class="anchor"></span><div class="para"> <p>For patients not at target LDL-C levels, used alone or in combination with other lipid-lowering therapies (eg, statins, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span>) for the treatment of adults with primary hyperlipidemia (including familial hypercholesterolemia)</p></div></td></tr><tr class="even"><td><span id="v88176774" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Evolocumab</span></p></div></td><td><span id="v88176776" class="anchor"></span><div class="para"> <p>Initial dose for primary hyperlipidemia: 140 mg subcutaneously every 2 weeks or 420 mg subcutaneously once monthly</p></div></td><td><span id="v88176778" class="anchor"></span><div class="para"> <p>For patients not at target LDL-C levels, used alone or in combination with other lipid-lowering therapies (eg, statins, <span class="genericDrug" data-showrollover="false">ezetimibe</span>) for the treatment of adults with primary hyperlipidemia (including familial hypercholesterolemia)</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176783" class="anchor"></span><div class="para"> <p>Statins (HMG-CoA reductase inhibitors) </p></div></p></td></tr><tr class="even"><td><span id="v88176786" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span></p></div><span id="v88176787" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span></p></div><span id="v88176788" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span></p></div><span id="v88176789" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span></p></div><span id="v88176790" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span></p></div><span id="v88176791" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Simvastatin</span></p></div></td><td><span id="v88176793" class="anchor"></span><div class="para"> <p>Variable† (see <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v990176" data-toggle="tooltip" title="Treatment" data-id="c3b2d96c-f191-4397-a8a4-36894049c3e2" data-itemid="47789936-4b59-4aec-9810-c84b2beaeb1b">Dyslipidemia</a><span id="c3b2d96c-f191-4397-a8a4-36894049c3e2" class="d-none xref"> <span class="tooltip-container"> <a href="./{47789936-4B59-4AEC-9810-C84B2BEAEB1B}.html#v990176"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment </span> Dyslipidemia is <i>elevation</i> of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/c/r/e/creamy-plasma-hypertriglyceridemia-davidson-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment" loading="lazy"> </span> </a> </span> </span>)</p></div></td><td><span id="v88176796" class="anchor"></span><div class="para"> <p>Patients with CAD should be given maximally tolerated statin dose</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v88176800" class="anchor"></span><div class="para"> <p>Other medications</p></div></p></td></tr><tr class="even"><td><span id="v88176803" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ivabradine</span></p></div></td><td><span id="v88176805" class="anchor"></span><div class="para"> <p>5 mg orally twice a day, increased to 7.5 mg orally twice a day if needed</p></div></td><td><span id="v88176807" class="anchor"></span><div class="para"> <p>Inhibits sinus node </p></div><span id="v88176808" class="anchor"></span><div class="para"> <p>For symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm who cannot take beta-blockers</p></div><span id="v88176809" class="anchor"></span><div class="para"> <p>In combination with beta-blockers in patients inadequately controlled by beta-blocker alone and whose heart rate > 60 beats/minute</p></div></td></tr><tr class="odd"><td><span id="v88176812" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ranolazine</span></p></div></td><td><span id="v88176814" class="anchor"></span><div class="para"> <p>500 mg orally twice a day, increased to 1000 mg orally twice a day as needed</p></div></td><td><span id="v88176816" class="anchor"></span><div class="para"> <p>Patients in whom anginal symptoms continue despite treatment with other antianginal drugs</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v88176386" class="anchor"></span><div class="para"> <p>* Clinicians may use different combinations of medications depending on the type of coronary artery disease that is present.</p></div></td></tr><tr><td colspan="3"><span id="v88176389" class="anchor"></span><div class="para"> <p>† Refer to the manufacturer's prescribing information or a drug information database for specific dosing information.</p></div></td></tr><tr><td colspan="3"><span id="v88176392" class="anchor"></span><div class="para"> <p>‡ Lower doses of Direct-acting oral anticoagulants are sometimes used, based on patient-specific risk factors.</p></div></td></tr><tr><td colspan="3"><span id="v88176395" class="anchor"></span><div class="para"> <p>§ Higher doses of <span class="genericDrug" data-showrollover="false">aspirin</span> do not provide greater protection and increase risk of adverse effects.</p></div></td></tr><tr><td colspan="3"><span id="v88176399" class="anchor"></span><div class="para"> <p>¶ Of low molecular weight <span class="genericDrug" data-showrollover="false">heparins</span> (LMWHs), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span> is preferred.</p></div></td></tr><tr><td colspan="3"><span id="v88176403" class="anchor"></span><div class="para"> <p>ACS <span class='symbol'>=</span> acute coronary syndromes; BP <span class='symbol'>=</span> blood pressure; CABG <span class='symbol'>=</span> coronary artery bypass grafting; CAD <span class='symbol'>=</span> coronary artery disease; HMG <span class='symbol'>=</span> hydroxymethylglutaryl; INR <span class='symbol'>=</span> international normalized ratio; LDL-C <span class='symbol'>=</span> low-density lipoprotein cholesterol; LV <span class='symbol'>=</span> left ventricular; MI = myocardial infarction; NSTEMI <span class='symbol'>=</span> non–ST-segment elevation MI; PCI <span class='symbol'>=</span> percutaneous intervention; STEMI <span class='symbol'>=</span> ST-segment elevation MI.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v27854207'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v27854208"></span> <div class="TableFullPage" id="v27854207"> <h3 class="title">IV Fibrinolytic Therapies</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v41360645" class="anchor"></span><div class="para"> <p>Medication</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v41360647" class="anchor"></span><div class="para"> <p>Circulating half-life (minutes)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v27854232" class="anchor"></span><div class="para"> <p>Concurrent <span class="genericDrug" data-showrollover="false">heparin</span></p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v27854235" class="anchor"></span><div class="para"> <p>Allergic reactions</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v27854250" class="anchor"></span><div class="para"> <p>Anistreplase</p></div></td><td><span id="v27854254" class="anchor"></span><div class="para"> <p>100</p></div></td><td><span id="v27854256" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v27854258" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="even"><td><span id="v27854261" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alteplase</span></p></div></td><td><span id="v27854265" class="anchor"></span><div class="para"> <p>6</p></div></td><td><span id="v27854267" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v27854269" class="anchor"></span><div class="para"> <p>Rare</p></div></td></tr><tr class="odd"><td><span id="v27854272" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Reteplase</span></p></div></td><td><span id="v27854276" class="anchor"></span><div class="para"> <p>13–16</p></div></td><td><span id="v27854278" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v27854280" class="anchor"></span><div class="para"> <p>Rare</p></div></td></tr><tr class="even"><td><span id="v49362171" class="anchor"></span><div class="para"> <p>Streptokinase (not available in the United States)</p></div></td><td><span id="v49362175" class="anchor"></span><div class="para"> <p>20</p></div></td><td><span id="v49362177" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v49362179" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="odd"><td><span id="v27854283" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tenecteplase</span></p></div></td><td><span id="v27854292" class="anchor"></span><div class="para"> <p>Initial half-life of 20–24 minutes; terminal phase half-life of 90–130 minutes</p></div></td><td><span id="v27854294" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v27854296" class="anchor"></span><div class="para"> <p>Rare</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v41360653'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v41360654"></span> <div class="TableHalfPage" id="v41360653"> <h3 class="title">Contraindications to Fibrinolytic Therapy</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td rowspan="6"><span id="v41360661" class="anchor"></span><div class="para"> <p>Absolute contraindications</p></div></td><td><span id="v41360663" class="anchor"></span><div class="para"> <p>Aortic dissection</p></div></td></tr><tr class="even"><td><span id="v41360666" class="anchor"></span><div class="para"> <p>Previous hemorrhagic stroke (at any time)</p></div></td></tr><tr class="odd"><td><span id="v41360669" class="anchor"></span><div class="para"> <p>Previous ischemic stroke within 1 year</p></div></td></tr><tr class="even"><td><span id="v41360672" class="anchor"></span><div class="para"> <p>Active internal bleeding (not menses)</p></div></td></tr><tr class="odd"><td><span id="v41360675" class="anchor"></span><div class="para"> <p>Intracranial tumor</p></div></td></tr><tr class="even"><td><span id="v41360678" class="anchor"></span><div class="para"> <p>Pericarditis</p></div></td></tr><tr class="odd"><td rowspan="7"><span id="v41360681" class="anchor"></span><div class="para"> <p>Relative contraindications</p></div></td><td><span id="v41360683" class="anchor"></span><div class="para"> <p>Blood pressure <span class='symbol'>></span> 180/110 mm Hg after initial antihypertensive therapy</p></div></td></tr><tr class="even"><td><span id="v41360686" class="anchor"></span><div class="para"> <p>Trauma or major surgery within 4 weeks</p></div></td></tr><tr class="odd"><td><span id="v41360689" class="anchor"></span><div class="para"> <p>Active peptic ulcer</p></div></td></tr><tr class="even"><td><span id="v41360692" class="anchor"></span><div class="para"> <p>Pregnancy</p></div></td></tr><tr class="odd"><td><span id="v41360695" class="anchor"></span><div class="para"> <p>Bleeding diathesis</p></div></td></tr><tr class="even"><td><span id="v41360698" class="anchor"></span><div class="para"> <p>Noncompressible vascular puncture</p></div></td></tr><tr class="odd"><td><span id="v41360701" class="anchor"></span><div class="para"> <p>Current anticoagulation (INR <span class='symbol'>></span> 2)</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>